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A B S T R A C T
Background
Patients in the terminal phase of a disease may have complex needs. It is often family and friends who play a central role in providing
support, despite health professional input and regardless of whether the patient is at home or elsewhere. Such informal caring may
involve considerable physical, psychological, and economic stresses. A range of supportive programmes for caregivers is being developed
including psychological support and practical assistance.
Objectives
To assess the effects of supportive interventions that aim to improve the psychological and physical health of informal caregivers of
patients in the terminal phase of their illness.
Search methods
We searched the Cochrane Central Register of Controlled Trials (CENTRAL, The Cochrane Library, Issue 2 2010); MEDLINE (1950
to May 2010); EMBASE (1980 to May 2010); PsycINFO (1872 to May 2010); CINAHL (1937 to May 2010); National Health
Service Research Register (2000 to November 2008) and Dissertation Abstracts (1716 to May 2010). We searched the reference lists
of relevant studies; contacted experts; and handsearched journals.
Selection criteria
Randomised controlled trials (RCTs) of interventions to support adults who were caring for a friend or relative with a disease in the
terminal phase. Interventions could include practical and emotional support and/or the facilitation of coping skills. Interventions could
support caregivers indirectly via patient care.
Data collection and analysis
Two authors independently screened citations against the selection criteria. Data were extracted by one author and checked by another.
This included extraction of any adverse effects. Risk of bias assessment was undertaken by two authors. We contacted trial authors to
obtain missing information. Trial data were combined, where appropriate, on the review’s primary outcomes.
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Main results
We included eleven RCTs involving 1836 caregiver participants. Nine interventions were delivered directly to the caregiver. Seven of
these provided support in the caring role, another involved a family life review, and one grief therapy. None provided practical support.
The other two interventions aimed to support caregivers indirectly via patient care. Overall the risk of bias is unclear, as all trials under-
reported methods.
There is low quality evidence that interventions directly supporting the caregiver significantly reduce psychological distress in the short
term (8 trials: standardised mean difference (SMD) -0.15; 95% confidence interval (CI) -0.28 to -0.02). There is also low quality
evidence that these interventions in the short term may marginally improve coping skills and quality of life, but neither results were
statistically significant (7 trials: SMD -0.05; 95% CI -0.24 to 0.14; 6 trials: SMD 0.08; 95% CI -0.11 to 0.26, respectively). One study
assessed physical outcomes, specifically sleep improvement, and found no difference (median effect 0.00). No study measured health
service use or adverse outcomes. In one study, however, a subgroup of intervention participants had higher levels of family conflict.
Evidence was less clear on the indirect interventions. While both trials in this category found that supporting the patient may reduce
psychological distress, none of the four assessments were statistically significant. There were no evaluations of coping with the caring
role, quality of life, service use or adverse outcomes. In one trial there was no difference between trial arms in the proportion of caregivers
reporting good physical health.
Authors’ conclusions
There is evidence that supportive interventions may help reduce caregivers’ psychological distress. These findings suggest that practi-
tioners should enquire about the concerns of caregivers and should consider that they may benefit from additional support. There is,
however, a need for further research to explore the benefits identified, and to assess the interventions’ effects on physical health, and
potential harms. Trials need to report their methods fully.
P L A I N L A N G U A G E S U M M A R Y
Interventions for supporting family and friends of patients at the end of life
Family and friends are often central to the care of patients at the end of life. While providing such informal care can generate strong
positive emotions, caring can be extremely stressful both mentally and physically. Support strategies are being developed. These can
involve, for example, advice on caring and practical support. However, it is unclear if these strategies are beneficial.
We conducted our review through searches for studies that were randomised controlled trials and that evaluated an intervention to
support family and/or friends of patients at the end of life.
We found 11 trials involving 1836 caregiver participants in total. The trials commonly evaluated an intervention that provided emotional
support and advice on coping. Two studies aimed to help support the family and friends indirectly by addressing the needs of the patient.
Apart from one trial providing patient care, none provided practical support. Trials compared those who received the intervention with
those who did not, to see if the intervention helped the family, family member or friend cope with their caring role. Trials commonly
evaluated the intervention by measuring whether it improved the caregiver’s general wellbeing.
The review found that interventions that directly support the family and/or friends help them to cope emotionally, and may help them
to cope with their role in caring and improve their quality of life. There were few assessments of the impact of the interventions on
physical health; one study found overall no difference in sleep improvement. No study looked at whether the interventions increased
or decreased the carers’ health service use or looked for potential harms, although higher levels of family conflict was identified in some
participants in one trial. Interventions that aimed to help support the family and/or friends indirectly via patient care, may also help
them cope emotionally. There were no assessments on whether the indirect interventions helped them cope with their role in caring,
improved quality of life, increased or decreased their health service use, or had potential harms. In one of these trials there was no
difference in caregiver physical health between those whose friend or relative had received the additional patient care, and those who
had not. The findings of some studies included in this review may be at risk of bias, because they under-report key design features and
may have been conducted poorly.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Population: informal caregivers of patients in the terminal phase of a disease
Outcomes Illustrative comparative risks* (95% CI) No of participants Quality of the evidence Comment
Assumed risk Corresponding risk
Control Direct intervention
Psychological distress The mean score for psycho-
logical distress ranged across
control groups from 0.4 to 12
The mean psychological dis-
tress in the intervention groups
was 0.15 standard deviations
lower (0.28 to 0.02 lower)
936 (8 studies) ⊕⊕©©
low1,2
Coping with the caring role The mean score for coping
with the caring role ranged
across control groups from -
139 to 71
The mean coping with the
caring role in the intervention
groups was 0.05 standard de-
viations lower3 (0.24 lower to
0.14 higher).
738 (7 studies) ⊕⊕©©
low1,2
Quality of life The mean score for quality
of life ranged across control
groups from -48 to 65
The mean quality of life in the
intervention groups was 0.08
standard deviations higher (0.
11 lower to 0.26 higher)
631 (6 studies) ⊕⊕©©
low1,2
Physical health: sleep quality See comment See comment 30 (1 study) ⊕⊕©©
low1,2
The median effect size of the eight evaluations
undertaken in the study was 0.00
Health service use See comment See comment None of the 9 studies measured health service
use
Adverse events See comment See comment None of the 9 studies set out to measure
adverse events but in one study a subgroup
of intervention participants had higher levels of
family conflict
CI: Confidence interval3
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GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our confidence in the estimate of effect.
Moderate quality: Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.
Low quality: Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.
Very low quality: We are very uncertain about the estimate.
1. Not all studies provided/study did not provide full methodological details.
2. It is difficult to exclude the risk of publication bias.
3. Outcome expressed as the lower the better in coping with the caring role.
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
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B A C K G R O U N D
The terminal phase of a disease is defined as the stage when a
person’s disease is not amenable to cure, their health is progressively
deteriorating and the health professionals involved in their care do
not expect them to survive longer than days, weeks or months. At
this time, the aim of treatment is supportive or palliative, in order
to ensure maximum comfort for patients and ease of coping for
those close to them. In this final phase of life a person may have
complex care and support needs, and many concerns. Needs may
include: symptom management; emotional and spiritual support;
assistancewith personal and instrumental care; transportation; and
the monitoring and assessment of, and help with, communication
with health professionals about disease progression and palliative
treatment.
It is often family members and friends who play a central role
in providing care, despite health professional input and regardless
of whether the patient is at home or in a formal healthcare set-
ting. Although such informal caregivers (for clarity hereafter ex-
pressed as caregivers) often undertake the role and derive personal
rewards, such as greater meaning, purpose and commitment from
care giving (Horowitz 1985; Hudson 2005; Nijboer 2001), being
a caregiver may also involve considerable physical, psychological,
economic and domestic challenges. These can take their toll on
a caregiver, who also needs to deal with their own sorrow and
sense of impending loss. Such challenges and stresses, sometimes
called caregiver burden, can affect aspects of caregivers’ wellbe-
ing; they may feel isolated and lack time to reflect on their own
needs and regain energy. It may also affect their own health, re-
sulting in fatigue, sleeping problems, weight loss, depression, anx-
iety and an increased risk of death (see, for instance: Low 1999;
Pinquart 2007; Schulz 1999; Schulz 2004; Thomas 2002). Fam-
ily and friends often have their own emotional and physical dis-
tress, experience financial strain, have to cope with medical de-
cisions and may have other dependants.These issues may impact
on the patient, affecting the quality and duration of their home
care (Gomes 2006; Higginson 2008; Holicky 1996). The public
health implications of caregiving include use of health care by the
caregivers themselves in addition to patients. As populations age,
the impact of such effects increases; palliative care is shifting into
patients’ homes with longer survival time in the terminal phase.
These effects are compounded by more potential caregivers work-
ing away from home and by increased social mobility, with the re-
sult that fewer family members are available to commit to regular
caregiving than was the case a generation ago.
Healthcare policies in a number of countries recognise that care-
givers of patients in the terminal phase may require a wide range of
support, including information about the disease process and per-
sonal support. Resources are also needed for emotional distress, for
spiritual wellbeing, and for physical needs such as adequate sleep,
in addition to domestic help and financial support (see for in-
stance, the WHO National Cancer Control Programmes (WHO
2002), the UK NHS Cancer Reform strategy 2007 (DH Strategy
2007), the US National Family Caregiver Support Program (US
DHHS 2003) and the Australian National Palliative Care Pro-
gramme (DHA 2008)). Whilst support for caregivers is a core
tenet of palliative care philosophy, and in some countries chari-
table organisations offer caregiver support, it is not uncommon
that caregivers’ needs are unmet (see for instance Osse 2006 and
Soothill 2003). Caregivers may have considerably more unmet
psychosocial needs than the patients themselves (Soothill 2003).
In their review of the literature on palliative caregiver support ser-
vices Harding et al (Harding 2003) conclude that since the main
focus of specialist palliative care services is the patient, it is not
surprising that caregivers’ needs remain unmet. It is also likely that
healthcare providers do not always know how or when to provide
support to caregivers, and may feel it is beyond their skills and
resources to do so. Addressing caregivers’ needs is not straightfor-
ward. Their needs may be broad ranging and may change during
the period of caregiving, as well as in the bereavement phase. This
complexity may explain why support for caregivers is less devel-
oped than other aspects of palliative care services. Caregivers may
also not recognise or, in an attempt to avoid redirecting resources
away from the patient, may be reluctant to seek support for their
ownneeds. Theymay feel a need to preserve self-reliance, indepen-
dence, dignity and familiar aspects of life (Grande 1997; Soothill
2003). By revealing their own needs, caregivers may worry that
health professionals might conclude that they are not able to care
appropriately for their loved one.
A wide range of healthcare programmes and strategies are being
developed and implemented that aim to support caregivers. This
support has a number of general aims:
• to reduce the amount of care provided by a caregiver, for
example by offering respite services;
• to improve coping skills, for example by providing
programmes that facilitate problem solving;
• to improve wellbeing, for example by providing
psychological programmes such as counselling, relaxation and
psychotherapy;
• to deliver such interventions at an appropriate time
(’window of opportunity’).
The importance of evaluating these strategies for caregivers in gen-
eral, and for those involved in terminal care specifically, is recog-
nised by several organisations, for example, the International Pal-
liative Care Family-Carer Research Collaboration 2007 (http://
www.ipcfrc.unimelb.edu.au/) and National Institute for Clinical
Excellence (NICE 2004).
There is some evidence on the impact of such interventions in
related topics. In a narrative review of evaluations of interventions
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for caregivers of older patients with a chronic, severe and progres-
sive disease, or a physical disability, Sörensen and colleagues iden-
tified 78 studies (Sörensen 2002). Although they noted a lack of
random assignment to treatment and control groups in many of
these studies, they concluded that interventions which provided
psychological support, were educational (such as providing infor-
mation about the care recipients’ disease process), aimed to en-
hance caregivers’ coping skills, or provided a combination of such
interventions, appeared effective in the short term in ameliorating
caregiver burden and depression as well as increasing caregiver sat-
isfaction, ability and knowledge. The interventions also seemed
to reduce symptoms in the patient who was the focus of care. Since
the publication of this review, interventions intended specifically
to support caregivers of patients in the terminal phase have been
evaluated in controlled comparison studies. These commonly as-
sess interventions aimed to improve ‘wellbeing’ such as quality of
life and emotional health. Wellbeing is perhaps more consistently
measured in studies compared to other outcomes, such as health
service use. However, the context of caring for a dying relative
can be extremely stressful and it is likely that any intervention to
improve support will have a limited impact on improving the dis-
tressing outcome of that experience.
The evidence base on trialled interventions to support family and
friends caring for patients in the terminal phase of disease has not
been reviewed systematically and it remains unclear:
• which type(s), elements or combinations of interventions or
services have been evaluated;
• which interventions provide greater potential benefit to
caregivers and are more acceptable;
• how interventions are best delivered - as part of care services
for the patient or as a separate programme of support; and
• which caregivers (such as those at higher risk) might benefit
most.
O B J E C T I V E S
Toassess the effects of supportive interventions that aim to improve
the psychological and physical health of informal caregivers of
patients in the terminal phase of their illness.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs). We anticipated
that there would be few, if any, RCTs in this area and intended to
include a range of study types, specifically RCTs, quasi RCTs, con-
trolled before-and-after studies and interrupted time series stud-
ies. However, as our search identified 11 RCTs, we chose to limit
the review to RCTs, as they provide a higher level of evidence of
effectiveness.
Types of participants
We included adults (at least 18 years of age) who were caring infor-
mally for a friend or relative with a disease in the terminal phase.
We defined a caregiver as an unpaid person providing physical,
practical and/or emotional care and support to a relative or friend.
We planned to include evaluations where caregivers were in receipt
of financial or other benefits in recognition of their caregiving role
and to take account of this additional support in our interpreta-
tion of the results. We did not exclude, however, trials that did not
provide an indication of caregiving. This was based on the assump-
tion that such close persons (i.e. family and/or friends) would be
involved to some extent in the supportive care of the patient by
the nature of their relationship, and also because the patient had
reached the terminal phase. We recorded, where reported, the ex-
tent of caregiving and planned to explore this factor in subgroup
analysis.
We included studies in which the care recipient (the patient) had a
terminal disease and met one or more of the following criteria: (1)
disease stage described as ’at an advanced stage’, ’terminal stage’,
’end-stage’, ’end-of-life’, ’dying’, (2) a prognosis of less than a year,
(3) health was progressively deteriorating or (4) was receiving pal-
liative care. Care recipients with diseases in the terminal phase
may have included, but were not restricted to, people with cancer,
chronic obstructive pulmonary disease (COPD), heart failure or
AIDS. Care recipients could have been living at home, in the com-
munity, or any healthcare setting such as a hospital or a hospice.
Types of interventions
Studies were included if they evaluated an intervention that aimed
to provide support to the caregiver in addition to usual care. These
interventions could have provided support directly and involved
one ormore of the following (1) practical support such as domestic
or respite services; (2) aim to increase coping skills, for example by
providing programmes that develop problem solving; or (3) aim
to enhance wellbeing, for example by providing counselling, re-
laxation or psychotherapy. Interventions could also have provided
support indirectly by providing, for example, support for patients
such as a palliative care intervention. Health professionals, other
professionals or lay persons could have delivered the intervention.
To reduce the risk of reporting bias, trialswere only included if they
stated that a main aim of the evaluation was to assess the impact
of the intervention on the caregiver, as opposed, for example, to
a secondary analysis on trial data that was collected to answer a
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different research question, such as the impact of the intervention
on the patient only.
Specific comparisons included usual patient care and other forms
of the intervention, or input from palliative care services. Usual
care (which may be specialist or generalist for patients in the ter-
minal phase) was likely to include varying levels of caregiver sup-
port offered either directly or indirectly, and may not have been
itemised or defined. However, in the true spirit of randomised
trial methodology, these known and unknown differences were
assumed to be accounted for in the randomisation.
Types of outcome measures
Primary outcomes
1. Psychological health outcomes included measures of
psychological distress such as symptoms of depression, anxiety or
feelings of hopelessness, measures of quality of life (QOL) or
wellbeing, and ability to cope with the stresses of caring for a
terminally ill family member such as caregiver strain or
experiencing a negative appraisal of their caregiving role.
2. Physical health outcomes such as fatigue, tiredness and
sleeping difficulties.
3. Service delivery outcomes including health service use.
4. Adverse outcomes.
Secondary outcomes
1. Acceptability to the caregiver.
2. The caregiver’s knowledge of the patient’s disease process,
and of resources and services available to support them in
providing care.
3. The perceived impact on the care received by the patient,
such as the duration of and satisfaction with care, and place of
death.
4. The impact on caregiver bereavement.
5. Cost evaluation.
Search methods for identification of studies
Electronic searches
We searched the following electronic databases:
• The Cochrane Central Register of Controlled Trials
(CENTRAL, The Cochrane Library, Issue 2 2010);
• MEDLINE (OVID) (1950 to May 2010);
• EMBASE(OVID) (1980 to May 2010);
• PsycINFO (OVID) (1872 to May 2010);
• CINAHL (EBSCO) (1937 to May 2010);
• National Health Service Research Register (2000 to
November 2008);
• Dissertation Abstracts (INDEX TO THESES) (1716 to
May 2010);
Search terms
The search terms we used reflected components of our research
question: A) Intervention, B) Caregiver, and C) Terminal phase.
We tailored search strategies to databases. There were no language
or date restrictions. The strategies for CENTRAL, MEDLINE,
EMBASE, PsycINFO, and CINAHL are provided in Appendix
1; Appendix 2; Appendix 3; Appendix 4; Appendix 5.
Searching other resources
We searched reference lists and undertook forward citation checks
of all included trials and relevant reviews identified. We con-
tacted experts in the field for advice as to other potentially relevant
studies (See Acknowledgements). We handsearched the following
peer-reviewed journals from January 2005 to May 2010: Pallia-
tive Medicine, Journal of Pain and Symptom Management, and the
British Journal of Psychiatry.
Data collection and analysis
Selection of studies
Two review authors (BC; LJ) independently screened all citations
against the selection criteria. Following screening, the same two
review authors assessed the full text of potentially eligible citations
for inclusion. If differences of opinion had arisen we planned to
discuss this with the other review authors (RD, BL, MK and AT)
and if resolution had been difficult, we planned to attempt to con-
tact the study authors for clarification. We documented studies ex-
cluded after full text assessment, giving reasons (see Characteristics
of excluded studies).
Data extraction and management
Two review authors (BC and LJ) independently extracted data
from the included studies. A data extraction form was designed
for this review. Where possible, the following information was
extracted for each trial:
• Type of intervention and terms used to describe the disease
stage.
• The number of caregivers eligible, the number randomised,
and reasons why any caregivers were not included in the trial.
• The number of caregivers evaluated at follow-up(s), reasons
for loss to follow-up, and how the trials, if stated, handled
deviations from randomised allocation and missing response.
• Caregiver characteristics, namely the relationship to the
patient (such as spouse or adult child), age, gender, health,
physical function, whether caregiver and patient were living in
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the same household, and whether the caregiver received any
financial or other benefit for their role.
• Patient characteristics including the type of setting in which
the patient was being cared for, as well as their age, gender,
terminal disease, physical functionality and co-morbidities.
• The number of hours provided in caregiving and the level
and nature of care, including duration of caregiving.
• Study design features including masking [MP: Is this the
same as blinding? If so, please call it blinding], and features of
randomisation.
• Content of the intervention including the aim, who
delivered it, duration and number of sessions and the mode of
delivery (including whether it was conducted with individuals or
in a group setting). We also reported whether the content of the
intervention was standardised by the use of a manual.
• Comparison intervention including content, duration and
mode of delivery.
• Outcome quantitative data at the end of treatment and at
the end of follow-up, including how it was measured.
• We also planned to extract any qualitative evidence in
included studies, such as analysis of participants’ views on the
value of the intervention.
Where information was lacking, we attempted to contact the trial
authors or trial sponsors. We successfully contacted the authors of
six trials (see Acknowledgements).
One author (BC) entered the extracted data in Revman and data
were checked by a second author; specifically LJ checked entries
on trial description and RD/BL checked entries on trial findings.
If there had been any discrepancies, the other review authors (MK
and AT) would have been consulted and discrepancy resolved by
consensus.
Meta-analytical framework: selection of outcomes
Wedeveloped ameta-analytical framework after the search toman-
age the diversity of outcomes found. Ideally, trials included in a
meta-analysis will use the same outcomemeasures at the same time
points, however the trials we identified posed several challenges.
The framework we developed recognises differences between the
trial evaluations, and has a broad remit on what trial data can be
combined to provide a pooled effect estimate while preventing the
loss of potentially relevant information. It follows an approach
used by the Cochrane Effective Practice and Organisation of Care
(EPOC) Review Group (Grimshaw 2003).
The framework addresses four specific issues:
• different interventions that aimed to facilitate change in a
similar manner;
• different outcomes that could be considered broadly similar;
• no primary outcome and more than one assessment to
measure similar outcomes, such as those relating to coping with
the caring role; and
• different follow-up times, for example a few days after trial
treatment phase to several months after patient’s death.
These issues were addressed in the following way:
Similar but different interventions
We initially grouped trial data based on similarity in terms of
how an intervention aimed to facilitate change. Specifically, we
considered whether the intervention was provided directly to the
caregiver or provided indirectly to the caregiver, such as giving
support to the patient.
Similar but different outcomes
We grouped outcomes which were different but which could be
considered broadly similar into three main areas: psychological
health; physical health; and service delivery.
a. Psychological health, which included three outcome subcate-
gories:
• Psychological distress, which included outcomes such as
symptoms of depression or anxiety.
• Coping with the caring role, which included outcomes such
as caregiver burden or stress or appraisal of caring role.
• Quality of life and wellbeing.
b. Physical health.
c. Service delivery outcomes including health service use.
Multiple outcomes per category
Some trials used multiple measures to assess similar categories
of outcomes, such as coping with the caring role measured by
perceived role preparedness, or competency in role, or level of
caregiver burden. We extracted all outcomes within a category
for each trial, standardised the direction of effect by multiplying
by -1 if scales were in opposite directions, and ranked the effect
estimates or the standardised mean effect which we generated for
ordinal outcomes. We report the median effect estimate for each
outcome, or, where there were an even number of outcomes, the
most conservative of the two centralmedian effect estimates. For all
trials reporting multiple outcomes, we used the median outcome.
Different follow-up times
Tomanage differences in the follow-up timeswe selected outcomes
at two follow-up time-points only:
• The first follow-up after the end of the intervention
programme. The choice of this time-point was to reduce the risk
of attrition bias which was likely to be high in these study
populations because of declining health or death. Some trials
included a booster or refresher phase, but to avoid dilution of
treatment effect we extracted data immediately after the bulk of
the intervention had been delivered.
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• The final follow-up. The choice of this time-point was to
capture longer term effects. However, as this time-point differed
across trials and had increased risk of attrition, we anticipated
that we would not be able to pool these data.
The Additional tables detail the effect estimates selected for the
trials included in the review.
Qualitative evidence
We planned that if any qualitative data were reported in the
included trials, we would extract this in consultation with the
CochraneQualitativeMethodsGroup. Such qualitative data could
have captured caregivers’ views on the value of the intervention.
Assessment of risk of bias in included studies
We assessed and reported on the risk of bias of included RCTs in
accordance with the guidelines of the Cochrane Consumers and
Communication Review Group (Template 2008), which recom-
mends the explicit reporting of the following elements for RCTs:
sequence generation; allocation concealment; blinding; complete-
ness of outcome data; and selective outcome reporting. For blind-
ing we only considered blinding of outcome assessors, i.e. data
collectors, as it would have been difficult because of the nature of
the intervention to blind the treatment provider or the recipient
of the intervention. For each domain we assessed whether there
was a low risk of bias (if the study matched the criteria), a high risk
(if the study did not match the criteria) or unclear risk of bias (for
example, because of under reporting), and reported this in Risk
of Bias tables (see Characteristics of included studies). We defined
trials as having an overall low risk of bias if they scored a low risk
of bias on four of the five domains in the risk of bias table. We
labelled a trial as having an unclear risk of bias if the trial provided
too few details to make a judgement of ’high’ or ’low’ risk. We also
assessed the intervention, in terms of whether there was a manual
used to guide the interventionist in how to deliver the interven-
tion, and whether there was sufficient information available for
the intervention to be replicated elsewhere.
Two review authors (BC and RD/BL) assessed the risk of bias of
included studies, with disagreements resolved by discussion and
consensus. Where possible we contacted study authors for addi-
tional information (See Acknowledgements).We incorporated the
results of the risk of bias assessment into the review through sys-
tematic narrative description and commentary about each item,
leading to an overall assessment of the risk of bias of included
studies and a judgement about the internal validity of the review’s
results.
Measures of treatment effect
Treatment effects were measured using dichotomous data, or or-
dinal rating scales.
Dichotomous data
Where dichotomous data were reported, we extracted or generated
odds ratios (ORs) and their 95% confidence intervals (CIs).
Continuous data
Where continuous data were reported, we extracted or generated
the mean difference (MD) from the means and standard devia-
tions. Effect measures for ordinal data were assessed as continuous
data.
Unit of analysis issues
For identified cluster randomised controlled trials we checked for
unit of analysis errors, and planned, if analysis errors were found
and sufficient data were available, to recalculate the results using
the appropriate unit of analysis (Higgins 2008).
Dealing with missing data
Missing studies can result from an inadequate search for data or
from publication bias in that papers with negative findings are
less likely to be published. How we dealt with this is detailed in
Search methods for identification of studies and in Assessment of
reporting biases.
We anticipated finding a significant amount of loss to follow-up
in this review, due either to the patient’s declining health and the
caregiver’s need for more time with their loved one, or because
of the death of the patient. We report attrition rates, per trial, in
the Risk of Bias tables (see Characteristics of included studies).
This included, if available, per trial arm reasons for attrition, and
whether the trial stated any re-inclusions performed in analyses.
We did not undertake any imputation formissing participant data.
A common itemmissing in outcome data is the standard deviation
(SD) for continuous outcomes.Where data were not reported, but
might be available we attempted to contact the study authors. If
contact with the author was not possible, we planned to calculate
or impute it using relevant data, only if a minority of the trials (to
be combined in ameta-analysis) had amissing SD (Higgins 2008).
If we had undertaken such imputation we would have performed
sensitivity analyses to assess its impact on combined analysis.
We did not exclude trials on the basis of missing data. In the
Discussion section we address the potential impact of missing data
on the findings of the review.
Assessment of heterogeneity
Where meta-analysis was possible, we assessed statistical hetero-
geneity between trials using the Chi2 statistic and I2 statistic (a
Chi2 P value of less than 0.05 or an I2 value equal to or more
than 50% was considered to indicate substantial heterogeneity). If
substantial heterogeneity was identified, we planned to undertake
subgroup analyses to investigate its possible sources.
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Assessment of reporting biases
Publication bias
We explored publication bias visually using funnel plots.
Data synthesis
As the interventions and patient populations were quite variable,
we employed random-effects meta-analyses. We planned to com-
pute an absolute risk reduction from the results of any meta-anal-
ysis of odds ratios (ORs). For outcomes where meta-analysis was
not appropriate, including for all secondary outcomes and all out-
comes at the end of follow-up, we provide information on the con-
sistency of effects across all trials using the median effect estimate,
the number of comparisons showing a positive direction of effect
of the intervention and the number of comparisons that showed
a statistically significant effect.
Summary of Findings table
We use a summary of findings table to present the main findings
of the review, specifically on the quality of the evidence, the sum
of available data on the main outcome and the magnitude of effect
of the interventions.
Subgroup analysis and investigation of heterogeneity
Subgroup analysis explores whether the overall effect varied with
different trial populations, and with the nature and content of the
interventions. Specifically, within the broad subgroups of direct
and indirect interventions, we planned to explore (1) whether the
intervention was composed of more than one distinct component,
and (2) what the intervention primarily aimed to improve, such
as coping by facilitating problem solving skills, or wellbeing by
providing relaxation therapies.
We also aimed to explore the modification effect of caregiver char-
acteristics by performing the following subgroup analyses:
1. Caregiver at higher risk of a negative outcome (Stroebe
2007)
2. Intensity of care giving (Abernethy 2008)
Sensitivity analysis
We planned to perform sensitivity analyses in order to explore (by
excluding trials) the influence of the following factors:
1. Unpublished trials
2. Trials that did not use a validated scale to measure
psychological wellbeing
3. Trials of high or unclear risk of bias.
Consumer participation
Wedeveloped a consumer advisory group that was consultedwhen
drafting the full review and will continue to be involved whenever
a significant amendment of the published review is considered.
Members of the group assisted the review authors to interpret the
outcomes, highlighted evidence gaps and ensured the review was
readable and understandable from a consumer perspective. Specif-
ically, this was undertaken by one consumer commenting on the
protocol, and review authors presenting to the group for their feed-
back on drafts of our findings and inviting them to comment on a
written draft before submission to the Cochrane Consumers and
Communication Review Group. The consumer advisory group
involved members of the North London Cancer Partnership Net-
work. Themajority of active members of this group are lay persons
including people with terminal cancer, survivors of cancer, as well
as caregivers of patients with a terminal illness.
Consumers were also involved in the standard peer review process
of the Cochrane Consumers and Communication Review Group,
providing feedback at protocol and review stages.
R E S U L T S
Description of studies
See:Characteristics of included studies; Characteristics of excluded
studies; Characteristics of ongoing studies.
Results of the search
Electronic searches generated a total of 8269 citations. Screening
of titles and abstracts identified 45 studies that were potentially
relevant. On full text, we excluded 34 of these studies, primarily
because they were not RCTs and/or they did not include care-
giver outcomes (see Characteristics of excluded studies). Follow-
ing completion of the searches, we identified a relevant new trial
through attending a palliative care conference, however its results
are not yet available (O’Hara 2010).
Included studies
Eleven relevant RCTs were identified (Addington-Hall 1992;
Allen 2008; Carter 2006; Hudson 2005; Kane 1984; Keefe 2005;
Kissane 2006;McMillan 2005;Northouse 2005;Northouse 2007;
Walsh 2007). Seven trials were conducted in America (Allen 2008;
Carter 2006; Kane 1984; Keefe 2005;McMillan 2007; Northouse
2005; Northouse 2007), two in Australia (Hudson 2005; Kissane
2006), and two in the UK (Addington-Hall 1992; Walsh 2007).
Eight of the eleven trials included more than 100 participants
(Addington-Hall 1992; Hudson 2005; Kane 1984; Kissane 2006;
McMillan 2005; Northouse 2005;Northouse 2007;Walsh 2007).
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In total the eleven trials analysed outcomes for 1836 caregivers of
patients in the terminal phase of disease.
Informal caregivers
Caregiver participants in the trials were, where reported, middle-
aged spouses or an adult child of the patient. In ten trials the mean
age of the caregivers was between 50 and 65 years, in the other
trial details on age were limited (Addington-Hall 1992).
Trials provided limited details on the level of caregiving. Four tri-
als provided details on the amount of caregiving provided by the
trial participant to the patient (Allen 2008; Carter 2006; Hudson
2005; Walsh 2007). These were measured quite differently. One
study reported the mean length of care provision, which was 16
weeks (Hudson 2005), while another trial reported that the aver-
age amount caregiving per day was 17 hours (Carter 2006). Two
other studies had specific caregiving requirements for participant
inclusion. To be eligible in one the caregiver had to provide sup-
port to the patient for at least one activity of daily living per week
(Allen 2008), whereas in the other study the caregiver had to be
the main person providing unpaid practical and emotional sup-
port to the patient on a regular basis (Walsh 2007).
Three trials looked at caregivers with greater risk of a poor out-
come (Carter 2006; Kissane 2006; Walsh 2007). In these trials,
eligibility criteria for the caregivers were: those who reported hav-
ing difficulty with initiating or maintaining sleep, or had non-
restorative sleep for at least one month (Carter 2006); families at
risk of poor psychosocial outcome based on the Family Relation-
ships Index (Kissane 2006); and those with measurable emotional
distress using the General Health Questionnaire (Walsh 2007).
Care recipients
Care recipients were, as per our review’s inclusion criteria, patients
in the terminal phase of a disease. Apart from one trial (Allen
2008) all care recipients had a type of cancer. In eight trials patients
resided at home (Allen 2008; Carter 2006; Hudson 2005; Keefe
2005; Kissane 2006; Northouse 2005; Northouse 2007; Walsh
2007). No details were provided in the trials on the patients’ care
needs.
Patients were described as: not expected to live longer than six
months (Kane 1984; Keefe 2005; McMillan 2005; Walsh 2007)
or a year (Addington-Hall 1992); as being at an advanced dis-
ease stage (Allen 2008; Carter 2006; Keefe 2005); as having func-
tional decline (Allen 2008); and/or as receiving palliative care
(Hudson 2005; Kissane 2006; McMillan 2005; Walsh 2007). In
the Northouse 2007 trial prostate cancer patients were recruited
either at diagnosis, on biochemical recurrence or at an advanced
stage of the disease. This trial was included as randomisation was
stratified by phase of disease, and in their analysis the authors
found that effectiveness of the intervention was not moderated by
disease phase. In Northouse 2005, patients were eligible if, after a
disease free interval, they had had within the previous month or
so a diagnosis of breast cancer recurrence.We included this trial as
the majority (84%) of patients had reached the stage where their
cancer was likely to be at an advanced stage, i.e. had metastasised.
The mean age of patients was reported in seven trials and ranged
from 54 to 71 years (Kane 1984; Keefe 2005; Kissane 2006;
McMillan 2005; Northouse 2005;Northouse 2007;Walsh 2007).
In ten trials all patients were diagnosed with a cancer (Addington-
Hall 1992; Carter 2006; Hudson 2005; Kane 1984; Keefe 2005;
Kissane 2006;McMillan 2005;Northouse 2005;Northouse 2007;
Walsh 2007). In two of these trials patients had a particular type
of cancer; in the Northouse 2005 trial all patient participants were
women with breast cancer, while in the trial by Northouse 2007
all were men with prostate cancer. In the eleventh trial the patients
were mixed in diagnoses, including having general disability, a
variety of multiple chronic illnesses, heart disease or cancer (Allen
2008).
In eight trials patients resided in their own home (Allen 2008;
Carter 2006;Hudson 2005;Keefe2005;Kissane 2006;Northouse
2005; Northouse 2007; Walsh 2007). In another trial the patients
were receiving community-based hospice care, which suggested -
although it is not specifically reported - that these patients were
also residing at home (McMillan 2005). In one trial patients were
enrolled in a hospice program that involved inpatient and home
care (Kane 1984). In another, at recruitment the patients were a
mix of inpatients and outpatients (Addington-Hall 1992). None
of the trials reported the patient’s care needs.
Interventions
Nine studies trialled interventions aimed at supporting the care-
giver directly (Allen 2008; Carter 2006; Hudson 2005; Keefe
2005;Kissane 2006;McMillan 2005;Northouse 2005;Northouse
2007; Walsh 2007) and the other two trials were of interven-
tions aiming to support the caregiver indirectly via patient sup-
port (Addington-Hall 1992; Kane 1984). Nine interventions in-
volved a nurse (Addington-Hall 1992; Carter 2006; Kane 1984;
Keefe 2005; McMillan 2005; Hudson 2005; Northouse 2005;
Northouse 2007; Walsh 2007). The intensity of the intervention,
where reported, varied from two (Carter 2006) to nine (Kissane
2006) contact sessions. Apart from a hospice care intervention
(Kane 1984) none of the interventions provided any type of prac-
tical support.
Direct interventions
In nine trials the interventions aimed to directly support the
caregiver (Allen 2008; Carter 2006; Hudson 2005; Keefe 2005;
Kissane 2006;McMillan 2005;Northouse 2005;Northouse 2007;
Walsh 2007). In five of these trials the intervention was also di-
rected at the patient (Allen 2008; Keefe 2005; Kissane 2006;
Northouse 2005; Northouse 2007). The interventions aimed to
facilitate coping skills in seven trials (Allen 2008; Hudson 2005;
Kissane 2006;McMillan 2005;Northouse 2005;Northouse 2007;
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Walsh 2007) and enhance wellbeing in two trials (Carter 2006;
Keefe 2005). None of the direct interventions in these nine trials
provided practical support.
Across the trials the interventions aimed primarily to target a
range of outcomes: to decrease caregiving stress and increase com-
munication (Allen 2008); to reduce emotional distress (Carter
2006), or anxiety (Hudson 2005); to increase quality of life (Keefe
2005; McMillan 2005), levels of preparedness, mastery, self-effi-
cacy, competence, rewards (Hudson 2005) or coping (McMillan
2005); to facilitate support and communication Northouse 2005;
Northouse 2007); and to reduce the morbid effects of grief
(Kissane 2006). All interventions were distinct from care or service
provision to the patient and their family.
Seven trials involved a nurse in delivery of the intervention (Carter
2006; Keefe 2005; McMillan 2005; Hudson 2005; Northouse
2005; Northouse 2007; Walsh 2007), although in two of these
the intervention was delivered either by a nurse or by a social
worker (Carter 2006; Walsh 2007). One trial was a grief therapy
intervention delivered by social workers who were qualified family
therapists (Kissane 2006). One trial did not report who delivered
the intervention (Allen 2008). The interventions ranged from two
(Carter 2006) to nine (Kissane 2006) contact sessions. One inter-
vention continued to be provided after the death of the patient
(Kissane 2006).
Five trials provided types of advice and support including facili-
tating problem-solving skills, emotional support, financial advice,
future planning and/or patient care education (Hudson 2005;
McMillan 2005; Northouse 2005; Northouse 2007;Walsh 2007).
One trial with three trial arms included a control group given usual
hospice care, one arm that acted as an attention-control group
where participants received supportive visits during which nurses
discussed the caregiver’s feelings and fears, and an intervention arm
in which the nurse spent the same amount of time with each par-
ticipant as in the supportive care arm, providing problem-solving
training and giving support to assist caregivers with their caring
andmanagement of the patient’s symptoms (McMillan 2005).We
only included the intervention arm and the usual control group
from this trial. We did not include the active treatment control as
the comparison arm as it was not relevant to our research question.
Both trials byNorthouse (Northouse 2005;Northouse 2007) eval-
uated the same intervention, the FOCUS programme, in differ-
ent populations. As well as aiming to improve coping strategies,
this intervention aimed to improve communication between the
patient and his or her family.
Two trials delivered the intervention to all the family (Allen 2008;
Kissane 2006). In one the intervention aimed to reduce stress and
increase family communication by undertaking a life review by
constructing a personal legacy, commonly involving the produc-
tion of a scrapbook of their life together (Allen 2008). The other
trial evaluated a family focused grief therapy intervention (Kissane
2006). The therapy aimed to prevent complications of bereave-
ment in families at risk of psychological morbidity by enhancing
family functioning and handling of conflict. An eighth trial aimed
to improve sleep quality by providing an intervention involving
stimulus control, relaxation, cognitive therapy and practical ad-
vice on sleep environment (Carter 2006). The ninth trial provided
pain management education and training to the patient and their
partner (Keefe 2005).
Indirect interventions
Two trials aimed to improve caregiver outcomes indirectly via pa-
tient support (Addington-Hall 1992; Kane 1984). Both aimed to
enhance the wellbeing of patients and their families. One inter-
vention was provided by a nurse (Addington-Hall 1992); the other
by a multidisciplinary hospice team of nurses, physicians, a chap-
lain, social workers and volunteers (Kane 1984). Neither reported
contact time between those who provided the intervention, and
the patients and their families.
The evaluated interventions formed part of care services for the
patient. One trial involved the impact of inpatient hospice care
(Kane 1984). The other evaluated care coordinators who acted as
’brokers’ of services. The coordinators’ role was to assess the need
for advice on how to obtain services and to contact the agencies
themselves if necessary; and to ensure that services were provided
and were well coordinated (Addington-Hall 1992).
Risk of bias in included studies
See Figure 1 and Figure 2.
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Figure 1. Methodological quality summary: review authors’ judgements about each methodological quality
item for each included study.
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Figure 2. Methodological quality graph: review authors’ judgements about each methodological quality
item presented as percentages across all included studies.
Because of under-reporting of some methodological design fea-
tures, overall the included trials had an unclear risk of bias. Only
one trial met our criteria for a low risk of bias (McMillan 2005).
Allocation
Sequence generation: Five of the eleven trials reported adequately
how they generated the random allocation sequence (Hudson
2005; Keefe 2005;Kissane 2006; McMillan 2005; Walsh 2007).
Allocation concealment: Four trials reported adequate methods to
conceal random allocation (Keefe 2005; Kissane 2006; McMillan
2005; Walsh 2007).
Blinding
Six trials provided details on blinding of the outcome assessor
(Addington-Hall 1992; Keefe 2005; Kissane 2006; McMillan
2005; Northouse 2005; Northouse 2007).
Incomplete outcome data
In five trials it is unclear if the authors adequately addressed incom-
plete outcome data (Addington-Hall 1992; Allen 2008; Hudson
2005; Kane 1984; Walsh 2007).
Selective reporting
In all trials there was insufficient information to permit judgement
of selective reporting.
Other potential sources of bias
Two trials were cluster randomised trials (Addington-Hall 1992;
Kissane 2006). Studies using this design are at increased risk of bias
(in terms of allocation concealment) if individuals are recruited
after the clusters had been randomised. They are also at an in-
creased risk of bias if clusters are missing from the analysis, and
if the statistical methods used do not account for the clustering.
Neither trial reported whether individuals were recruited to the
trial after clusters were randomised; neither reported that any clus-
ters were missing from analysis. Only in the trial by Kissane 2006
were methods for allocation concealment reported and statistical
methods used to account for clustering.
In our assessment of the standardisation of the intervention, seven
trials report standardising the implementation of the intervention
by use of amanual outlining the intervention delivery (Addington-
Hall 1992; Allen 2008; Keefe 2005; Kissane 2006; McMillan
2005; Northouse 2005; Northouse 2007). Two trials provided
limited details on the interventions (Addington-Hall 1992; Kane
1984).
Effects of interventions
See: Summary of findings for the main comparison Direct
interventions: primary outcomes on psychological health at end
of treatment phase
Outcomes evaluated
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All trials measured outcomes using validated psychometric scales.
Common outcomes were psychological distress, which was mea-
sured in ten trials (Addington-Hall 1992; Allen2008;Carter 2006;
Hudson 2005; Kane 1984; Keefe 2005; Kissane 2006; Northouse
2005; Northouse 2007; Walsh 2007), coping with the caring role
which was measured in seven trials (Allen 2008; Hudson 2005;
Keefe 2005; McMillan 2005; Northouse 2005; Northouse 2007;
Walsh 2007) and quality of life which was measured in five tri-
als (Allen 2008; Carter 2006; McMillan 2005; Northouse 2005;
Northouse 2007).
Trials measured outcomes using a variety of scales including:
• for psychological distress, the Hospital Anxiety and
Depression Scale (HADS) (Zigmond 1983), and the Centre for
Epidemiological Studies Depression Scale (CES-D) (Weissman
1977)
• for quality of life, the Caregiver Quality-of-Life Cancer
Scale (Weitzner 1999)
• for coping with the caring role, the Caregiver Burden
Interview (Montgomery 1989), and the Carer Strain Index
(Robinson 1983).
Trials varied in the length of follow-up, from one week after the
completion of the treatment phase (Allen 2008; Keefe 2005) to 13
months (Kissane 2006). In four trials evaluations were undertaken
into the bereavement phase (Addington-Hall 1992;Hudson 2005;
Kissane 2006; Walsh 2007); in one trial outcomes were measured
only in bereavement (Kissane 2006).
Qualitative data
None of the trials undertook a qualitative analysis of any data
collected.
Interventions and outcomes not evaluated
None of the trials evaluated health service use, costs, caregiver fa-
tigue, caregiver’s knowledge of the patient’s disease process, or their
knowledge of resources and services available to support them.
None of the included trials provided practical domestic support.
We identified no trials evaluating supporting caregivers of paedi-
atric patients.
Interventions directed at the caregiver
Nine trials evaluated an intervention that aimed to support the
caregiver directly (Allen 2008; Carter 2006; Hudson 2005; Keefe
2005;Kissane 2006;McMillan 2005;Northouse 2005;Northouse
2007; Walsh 2007). Eight of these trials evaluated psychological
distress (Allen 2008; Carter 2006; Hudson 2005; Keefe 2005;
Kissane 2006; Northouse 2005; Northouse 2007; Walsh 2007),
seven evaluated coping with the caring role (Allen 2008; Hudson
2005; Keefe 2005; McMillan 2005; Northouse 2005; Northouse
2007; Walsh 2007), and six quality of life (Allen 2008; Carter
2006; McMillan 2005; Northouse 2005; Northouse 2007; Walsh
2007).Combined analysis of these outcomes suggested these inter-
ventions are of benefit, but results were statistically significant only
for psychological distress. Apart from one trial evaluating sleeping
difficulties (Carter 2006), none of the trials evaluated caregiver
physical health.
Primary outcomes
Psychological distress
At the end of treatment
See Summary of findings for the main comparison, Analysis 1.1,
Figure 3.
Figure 3. Forest plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.1 Psychological distress.
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Seven of the eight trials measured psychological distress at the
end of treatment using one measure (Allen 2008; Carter 2006;
Hudson 2005; Keefe 2005; Northouse 2005; Northouse 2007;
Walsh 2007). The eighth trial used two assessments of psycholog-
ical distress: psychological morbidity and symptoms of depression
(Kissane 2006). Four of the eight trials measured symptoms of
depression (Allen 2008; Carter 2006; Kissane 2006;Walsh 2007),
onemeasured anxiety (Hudson 2005), two studiesmeasuredhope-
lessness (Northouse 2005; Northouse 2007) and one study mea-
suredmood (Keefe 2005). In the trial that reported two outcomes,
as per the meta-analytical framework we report the most con-
servative effect, namely psychological morbidity (Kissane 2006).
There was a total of 934 participants across these eight trials. The
interventions reduced psychological distress (Standardised Mean
Difference (SMD) -0.15; 95% CI -0.28 to -0.02). The I2 at 0%
indicates that heterogeneity between trials may not be important.
These findings are detailed in the Summary of findings for the
main comparison, where we conclude that the quality of the evi-
dence is low as not all trials provided full methodological details
and it is difficult to exclude the risk of publication bias. Table 1
provides details on selection of measures used in combined anal-
ysis.
Only one subgroup analysis and none of the planned sensitivity
analyses were possible. In a subgroup analysis exploring whether
the intervention effect varied in caregivers at a higher risk of poor
outcome, those in the intervention continued to have lower psy-
chological distress than the comparison group, but this was no
longer statistically significant (two trials: SMD -0.15; 95% CI -
0.46 to 0.16) (Carter 2006; Walsh 2007).
At the end of trial follow-up
See Table 2.
Five trials evaluated psychological distress at the end of the trial
follow-up (Carter 2006; Hudson 2005; Keefe 2005; Northouse
2007; Walsh 2007). The median effect size across trials was 0.05;
five of the seven evaluations showed a positive benefit in reducing
psychological distress, none were significant.
Coping with the caring role
At the end of treatment
See Summary of findings for the main comparison, Analysis 1.2,
Figure 4.
Figure 4. Forest plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.2 Coping with the caring role.
Two trials measured coping with the caring role at the end of
treatment using one measure (Allen 2008; Walsh 2007), the five
other trials used multiple assessments (Hudson 2005; Keefe 2005;
McMillan 2005; Northouse 2005; Northouse 2007). In com-
bined analysis (selecting the median effect where there were mul-
tiple outcomes) we included outcomes on rewarding interaction
(Hudson 2005), general mastery of task (McMillan 2005), uncer-
tainty (Northouse 2005), self efficacy Northouse 2007), and care-
giver strain (Keefe 2005;Walsh 2007).When combined, these tri-
als involved 738 patients and showed that the intervention com-
pared to the control marginally improved coping with the caring
role, but this was not statistically significant (SMD -0.05; 95% CI
-0.24 to 0.14). The I2 at 33% indicated some heterogeneity be-
tween trials. These findings are detailed in the Summary of findings
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for the main comparison, where we conclude that the quality of
the evidence is low as not all trials provided full methodological
details and it is difficult to exclude the risk of publication bias.
Table 3 provides details on selection of measures used in combined
analysis.
There were insufficient differences between trials to undertake any
of the planned subgroup or sensitivity analyses.
At the end of trial follow-up
See Table 4.
Four trials evaluated coping with the caring role at the end of
trial follow-up (Hudson 2005; Northouse 2005; Northouse 2007;
Walsh 2007); the median effect size across trials was -0.05. Twelve
of the thirteen evaluations showed a positive impact on coping; the
evaluation of active coping and self efficacy showed a significant
effect.
Quality of life
At the end of treatment
See Summary of findings for the main comparison, Analysis 1.3,
Figure 5.
Figure 5. Forest plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.3 Quality of life.
Four trials measured quality of life at the end of treatment using
one measure (Allen 2008; Carter 2006; McMillan 2005; Walsh
2007); two other trials used multiple assessments (Northouse
2005; Northouse 2007). The quality of life assessments included
an overall measure of quality of life (Carter 2006; McMillan
2005; Walsh 2007), physical quality of life (Northouse 2005),
mental quality of life (Northouse 2007), and subjective wellbeing
(Allen 2008). Combining results from these trials (Allen 2008;
Carter 2006; McMillan 2005; Northouse 2005; Northouse 2007;
Walsh 2007) resulted in a total of 631 patients and a small but not
statistically significant improvement favouring the intervention in
quality of life (SMD 0.08; 95% CI -0.11 to 0.26). The I2 at 19%
indicated some heterogeneity between trials. These findings are
detailed in the Summary of findings for the main comparison,
where we conclude that the quality of the evidence is low as not
all trials provided full methodological details and it is difficult to
exclude the risk of publication bias. Table 5 provides details on
selection of measures used in combined analysis.
There were insufficient differences in trials to undertake any
planned subgroup or sensitivity analyses.
At the end of trial follow-up
See Table 6.
Four trials evaluated quality of life at the end of trial follow-up
(Carter 2006; Northouse 2005; Northouse 2007; Walsh 2007).
Across these trials five of seven comparisons showed a beneficial
improvement in quality of life, of which only one (the evaluation
of physical quality of life) was significant. The median effect size
across the trials was 0.13.
Funnel plots for the meta-analyses on psychological distress,
coping with the caring role and quality of life at the end of
treatment
See Figure 6, Figure 7, Figure 8.
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Figure 6. Funnel plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.1 Psychological distress.
18Interventions for supporting informal caregivers of patients in the terminal phase of a disease (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Figure 7. Funnel plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.2 Coping with the caring role.
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Figure 8. Funnel plot of comparison: 1 Direct Interventions: Primary outcome at end of intervention -
Psychological health, outcome: 1.3 Quality of life.
The funnel plots for combined analyses on psychological distress,
coping with the caring role and quality of life were all asymmet-
rical, but the direction of the asymmetry does not indicate pub-
lication bias. As there were few trials and as this test typically has
relatively low power, publication bias cannot be excluded.
Physical health
At the end of treatment
See Table 7.
One trial assessed a physical outcome at the end of treatment in
caregivers, specifically sleep quality (Carter 2006). The median
effect size of the eight evaluations undertaken in the trial was 0.00.
Six of the eight evaluations showed greater sleep quality in the
intervention group compared with the control group, of which
only one was a significant improvement.
At the end of trial follow-up
See Table 8.
At the end of trial follow-up in same trial the median effect of
evaluations of sleep quality was 0.49, withmost of the assessments,
6/7, showing that the intervention improved sleep compared with
the control (Carter 2006). Two of the results were statistically
significant.
Service delivery
None of the trials assessed outcomes relating to caregivers’ health
service use.
Adverse outcomes
None of the trials set out to identify adverse outcomes. The authors
of one trial note that there were no negative outcomes of the
intervention (Hudson 2005). In the trial on family-focused grief
therapy, a subgroup of families in the intervention group fared
worse than similar families in the control group; these were those
classed as hostile in that they tended to reject help, had high family
conflict levels, poor cohesion, and poor expressiveness (Kissane
2006). Specifically, in this small group of participants (n = 19)
the trial researchers found that those in the intervention group
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had significantly more family conflicts at the end of follow-up (13
months after the treatment phase) than those in the control group.
Secondary outcomes
Bereavement grief
See Table 9.
Two trials assessed outcomes relating to caregiver bereavement
grief (Kissane 2006: Walsh 2007). In one trial they found no dif-
ference between groups in those experiencing more morbid forms
of distress and depression (Kissane 2006); in the other trial they
found groups were similar in the intensity of bereavement grief
experienced (Walsh 2007).
Acceptability of the intervention to the caregiver
See Table 10
One trial between the trial arms compared caregiver satisfaction
with care provision; it found no significant difference (Walsh
2007).
Three trials explored participants’ experience of the intervention
(Allen 2008; Carter 2006; Walsh 2007). In the Walsh 2007 trial,
caregivers in the intervention group were asked what they valued
most, and reported that it was the additional emotional support.
In the trial by Allen 2008, intervention families reported that the
process of undertaking the life review intervention did not evoke
feelings of discomfort. This trial also found that 81% (n = 14) of
the families were very satisfied with the intervention. In the third
trial, participants stated that the sleep intervention guidelines were
easy to understand and follow (Carter 2006).
Other secondary outcomes
The included trials did not measure any other of the secondary
outcomes including caregiver knowledge, perceived impact on pa-
tient care, or cost evaluation.
Other outcomes
At the end of treatment
See Table 11, Table 12, Table 13, Table 14.
Other outcomes at the end of treatment, including communica-
tion and social adjustment, were reported in five trials (Allen 2008;
Keefe 2005; Kissane 2006; Northouse 2005; Northouse 2007).
We did not combine these in meta-analysis because the outcome
was not an outcome of interest identified a priori. A higher pro-
portion of these assessments, 32/49, favoured the intervention,
although only three were statistically significant.
Three trials assessed caregiver outcomes (Allen 2008; Kissane
2006; Northouse 2007): namely communication between the
caregiver and patient (Northouse 2007); spirituality (Allen 2008);
social adjustment and family functioning (Kissane 2006). Four
of these assessments found the intervention improved outcomes,
of which one was significant (communication with patient (
Northouse 2007)).
Four trials evaluated psychological outcomes in patients (Allen
2008; Keefe 2005; Northouse 2005; Northouse 2007). The me-
dian effect size across trialswas 0.03; 17of the 26 evaluations found
the intervention improved psychological health, although only
one was significant (caregiver reporting patient is more talkative).
Three trials evaluated patient physical outcomes (Allen 2008;
Keefe 2005; Northouse 2007), five of the ten evaluations across
the trials showed a non-significant positive improvement favour-
ing the intervention. One trial assessed existential concerns, its
two assessments showed a non significant effect (Allen 2008).
Indirect interventions
Two trials aimed to improve caregiver outcomes indirectly via pa-
tient support (Addington-Hall 1992; Kane 1984). In one trial the
aim was to ensure that patients received appropriate and coordi-
nated healthcare services, that were tailored to the individual pa-
tient’s needs (Addington-Hall 1992). In the other they evaluated
the effectiveness of hospice care (Kane 1984). The caregiver out-
comes assessed were limited to psychological distress and physical
health. One trial provided data in a format that was inappropriate
for meta-analysis (Kane 1984). As this trial was published over 25
years ago, no attempt was made to contact authors to request data
on estimates for differences between trial arms. Overall across the
two trials, whilst many positive outcomes were found, only one
was significant.
Primary outcomes
Psychological distress
Both trials of indirect (patient-support) interventions evaluated
psychological distress (Addington-Hall 1992; Kane 1984). One
trial provided full details of the analyses (Addington-Hall 1992).
At the end of treatment
See Table 15.
In the Addington-Hall 1992 trial both outcomes showed a posi-
tive benefit of the intervention in reducing psychological distress,
although neither was significant.
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At the end of follow-up.
See Table 16
One trial assessed psychological distress at the end of follow-up
(Addington-Hall 1992). All three assessments found that those in
the intervention group had less psychological distress than those
in the control group, but none of the differences were significant.
In the other trial the researchers report overall, during the follow-
up, significant differences favouring the intervention group in re-
duction of symptoms of anxiety, but not for symptoms of depres-
sion (Kane 1984).
Coping with the caring role, quality of life, adverse outcomes
and service delivery
Niether trial assessed coping with the caring role, quality of life,
adverse events or service delivery.
Physical health
See Table 17.
One trial assessed physical health at the end of follow-up
(Addington-Hall 1992).There were no differences found between
the two trial arms in physical health.
Secondary outcomes
Acceptability of the intervention
See Table 18.
Both trials explored acceptability of the intervention (Addington-
Hall 1992; Kane 1984). In one they report no significant differ-
ence in care satisfaction between caregivers and patients in either
trial arm (Addington-Hall 1992). In the other trial they report
that whilst patients randomised to the hospice intervention were
overall more satisfied compared to the control group, this was not
replicated in their caregivers (Kane 1984).
Impact of the care received by the patient
See Table 19.
Both trials evaluated patient health and social service use (
Addington-Hall 1992; Kane 1984). In the Addington-Hall 1992,
trial four of the twelve comparisons showed a positive direction of
effect favouring those in the intervention group in increasing ac-
cess to support services, such as occupational therapy and physio-
therapy, but none of the effects were significant. The other trial re-
ports no significant difference in general hospital use (Kane 1984).
Other secondary outcomes
None of trialsmeasured other secondary outcomes, including care-
giver knowledge, impact on caregiver bereavement, or cost evalu-
ation.
Other outcomes
See Table 20, Table 21.
Both trials evaluated patient psychological distress (Addington-
Hall 1992; Kane 1984). Across the trials in three of the four out-
comes it is reported that those in the intervention group had less
distress than those in the control group, although none of the ef-
fects were significant. Both trials evaluated patient physical out-
comes. One reported no significant differences in physical out-
comes between the trial arms (Kane 1984). In the other, for ten of
the twelve assessments those in the intervention group had fewer
physical symptoms than those in the control group, although none
of the differences were significant (Addington-Hall 1992).
D I S C U S S I O N
Summary of main results
This review evaluates the effects of interventions designed to sup-
port informal caregivers of patients in the terminal phase of a dis-
ease. The evidence reported represents all of the meaningful data
from the included trials on the review’s primary outcomes at the
end of treatment and follow-up. Some of the review’s primary out-
comes received only limited assessment, notably caregiver physical
health, or were not assessed, as in the case of caregiver health ser-
vice use. Eleven RCTs involving 1836 caregiver participants met
the review’s inclusion criteria. The evaluated interventions var-
ied. Nine were delivered directly to the caregiver. These aimed to
support the caregiver in various ways, although commonly they
involved psychological support and advice on caring. The other
two trials evaluated interventions that aimed to provide support
indirectly, by addressing patient care needs. None of the studies
provided the carer with practical domestic support.
In combined analysis of eight trials totaling 934 participants, it
was found that interventions directed at the caregiver helped in
the short-term to buffer against psychological distress (Analysis
1.1). However, the estimated effect size was small: SMD -0.15.
In the other combined analyses it was found that, in the short-
term, caregivers who received the intervention compared to those
in the control group had a marginally better quality of life and
a marginally increased ability to cope with the caring role. How-
ever these findings were not statistically significant (Analysis 1.2;
Analysis 1.3). In the Summary of findings for themain comparison
we conclude that the quality of this evidence is low.
None of the trials set out to identify adverse outcomes. However,
one trial on family-focused grief therapy reported increased family
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conflicts in a subgroup of participants who received the interven-
tion (Kissane 2006).
The review is limited in providing a summary of the main results
for the two indirect (patient care) interventions as the outcomes
across the trials were variable. Evidence suggests,however, that they
may help buffer against psychological distress.
Overall completeness and applicability of
evidence
The body of evidence we identified allows a conclusion on the
objectives of the review. There was evidence of effectiveness on
interventions directed at the caregiver. However, because of the
limited amount of trial data, and the variability in the types of
interventions and in how they were evaluated, the review was lim-
ited in its capacity to answer other questions; specifically which
interventions provide greater potential benefit and are more ac-
ceptable, how they are best delivered and which caregivers might
benefit most.
The external validity of some of the evidence presented in this
review is affected by the risk of recruitment bias. In two of the
trials included, up to 50% of those invited to participate chose not
to (Hudson 2005; Kissane 2006). This is perhaps not unexpected
in this study population, but it suggests that these interventions
may not be appropriate to all caregivers. The generalisability of the
reviewfindings is also limited asmany of the trials had small sample
sizes, suggesting they were under-powered to find a true effect.
Caregivers were also predominantly caring for patients with an
end-stage cancer. Therefore findings may not be entirely relevant
to caregivers of patients with other diseases. Also not all potential
types of interventions, such as those that involve financial support
or practical support through respite care, and not all outcomes,
for example costs, have been evaluated.
How the results of this reviewfit into the context of current practice
differs as current provision of formal support for family and friends
who are caring for a loved one in the terminal phase of a disease
varies internationally. Many countries provide no such services.
Agreements and disagreements with other
studies or reviews
Our findings are in accordance with other reviews on caregiving in
the terminal phase, in that the available evidence is based on a wide
variety of interventions,making comparison and pooling of results
difficult (Harding 2003; Ingleton 2003; Hudson 2004; Grande
2009; Stajduhar 2010). One related systematic review undertook
meta-analyses on interventions for family caregivers of cancer pa-
tients (Northouse 2010). It included 29 trials, of which only four
were included in our review because of differences in inclusion
criteria. The Northouse review accords with our findings in that it
found the interventions improved psychological wellbeing in the
short-term, although in only four of the authors’ nine combined
assessments was this significant.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
The review findings suggest that, at the very least, healthcare prac-
titioners should enquire about the concerns of family and friends
involved in caring for a loved one and should consider that they
may benefit from additional support to help them cope with car-
ing. Although it is unclear from this review which types of support
may be of more benefit, emotional support and information on
managing the care of their loved one were common features of the
interventions that were found to help buffer against psychological
distress.
Implications for research
The interventions evaluated should be repeated in sufficiently
powered rigorous trials in other populations. These trials should
include, as appropriate, outcome measures where analysis suggests
the interventions may benefit caregivers, such as for psychological
health, as well as outcomes under-, or not yet, evaluated, includ-
ing health service use. Studies should also set out to report any
adverse effects, such as for instance an intervention causing greater
emotional distress.There is also the need to evaluate interventions
that involve practical support. Future trials should fully report key
methodological design features.
Although goingbeyond the evidence generated in this review, there
is the need for more theoretical and conceptual work to inform
intervention design (Grande 2009). This includes further research
on identifying those at in greater need of support (Hudson 2005;
Kissane 2006).
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Addington-Hall 1992
Methods Randomised parallel controlled trial: cluster randomisation by general practice, stratified
by number of partners and postal district
Participants Caregivers: 118 caregivers were interviewed at least once. 84% of caregivers lived with
patient, 65% were married to patient and 30% were male. Does not provide details on
the level of caregiving
Patients: 203 UK terminally ill cancer patients (common cancers were breast, lung and
colon); male and female (n = 109). Patients were expected to live less than a year. Over
50% were 75 years or older
Interventions Directed at the patient.
Aim: To evaluate the effects on patients and their families of coordinating care services
Interventionist: Two community qualified nurses.
Duration: No details.
Content: The nurses’ role was to ensure that patients received appropriate and coordi-
nated healthcare services, that were tailored to the individual patient’s needs and circum-
stances. The nurses offered advice to the family on how to obtain services and, if nec-
essary, contacted the services themselves. Services were within the NHS, local authority
and voluntary sector. The nurses kept in regular contact with patients and their families
to assess their changing needs. They encouraged patients to contact them if they needed
help or advice. The intervention did not provide any practical support or counselling
Standardisation: The intervention was not manualised.
Comparison group: Patients continued to receive routinely available services
Outcomes Caregiver: Satisfaction with care, impact of caring on day-to-day life, and physical health.
Psychological health was assessed using the Leeds Depression and Anxiety Scale. Out-
comes were assessed up to 8 weeks following the patient’s death
Patient: The presence and severity of physical symptoms, psychiatric morbidity, use of
treatments, quality of life using the Spitzer Quality-of-Life Index, use of care services,
access to benefit entitlement, satisfaction with care and place of death
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
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Addington-Hall 1992 (Continued)
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessor: ’Independent inter-
viewers, who were not informed which
group the patients were in, interviewed pa-
tients at home’
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 118 caregivers were interviewed at least
once, 94 were interviewed around 8 weeks
following the patient’s death. 281/554 pa-
tients who entered the study completed
baseline interview, of which 203 completed
at least one follow-up interview (most com-
mon reason for loss to follow up was death
(n = 194)).The authors do not state any re-
inclusions in analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
Allen 2008
Methods Randomised parallel controlled trial pilot study.
Participants Caregivers: American family members who had at least weekly face-to-face contact with
the patient to provide assistance with activities of daily living (ADL), andwere cognitively
intact as measured by a score of 24 or greater on the Mini Mental State Examination
(MMSE)
Mean age was 55 years (SD 15.23) in the intervention group and 58 years (SD 10.
42) in the control group. Most caregivers were female (79% in control and 88% in
intervention). 71% in intervention and 65% in control were African American. Mean
years in education were 15 years (SD 3.14) in the intervention group and 14 years (SD
2.49) in the control. Does not provide details on level of caregiving (but all patients
required assistance with activities of daily living (ADL))
Patients: 31 male and female (n = 23) patients. Eligibility included living in the commu-
nity, aged 60 or older, having a life-limiting (does not define this any further) illness or
combination of chronic illnesses, approaching the end of life, has functional decline, and
receiving assistance in ADL. The diagnoses of patients varied: around half were classified
as either general debility or multiple chronic illnesses, 7/31 had heart disease and 3/31
had cancer
Interventions Directed at the family.
Aim: To evaluate an intervention designed to decrease caregiving stress and increase
family communication
Interventionist: No details provided.
Duration: The intervention involved 3 home visits.The first session averaged in length
82minutes, the second 66minutes and the third 70minutes. Between sessions the family
was given homework
Content: Intervention involved legacy activities. The researchers defined these as activities
that aimed to initiate the process of life review, that can be enjoyed by the family and
friends before and after the patient’s death.The intervention activities involved generating
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Allen 2008 (Continued)
a scrapbook of photographs or an audiotape of stories
In the first session a problem solving approach was used to help patients and their
families identify a legacy project, it involved coaching family members in generating and
sharing positive memories. They were then guided into focusing on a time period in
the patient’s life that could be adequately represented in a project. They were given a
specially designed notebook to help construct their legacy project. It was planned that at
the third session the family would share its legacy project with the interventionist. The
family was encouraged to construct other legacy projects
Standardisation: manual based.
Comparison group received 3 supportive phone calls. At the end of the intervention
period those in the comparison group received the specially designed legacy participant
notebook and guidance in how to construct a legacy
Outcomes Caregiver and patient outcomes: Wellbeing (three questions developed specifically for
the study. They were designed to capture perception of life satisfaction), and depression
using the Center for Epidemiological Studies Depression scale (CES-D)
Caregiver stress assessed using the Caregiver Stressors Scale. This measured caregiving
competency, strain, role overload, role captivity and emotional control
Patients: Symptoms of pain, tiredness, nausea, drowsiness, appetite, and shortness of
breath measured using the Edmonton Symptom Assessment Scale. This was completed
by patients and caregivers. Patient and caregivers independently completed visual ana-
logue scales in reference to patient on talkativeness, weight loss and agitation. Indices
from the Brief Mulidimensional Measure of Religion and Spirituality to assess daily spir-
itual experience
Assessed at 9 to10 weeks from baseline (one week after intervention finished)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Sequence generated using a random num-
ber generator. Block randomisation strati-
fied by race
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk Outcome assessor: No information pro-
vided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 42/47 completed baseline assessment, rea-
sons for 5 dyads discontinuing were: pa-
tient too cognitively impaired to consent
(n = 2), patient changed his/her mind (n
= 3). 31/47 families completed the trial,
does not provide reasons for the 11 dyads
who discontinued the trial later but states
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Allen 2008 (Continued)
that they were not significantly different
to those who completed in age, education,
and mental or health status. CES-D was
missing at baseline for 9 couples. Two of
the 31 patients and caregiver dyads were as-
sessed at first follow-up only completed the
first intervention session. The authors state
they were included in the analysis using an
intention-to-treat design but do not state
how the analysis was performed
Selective reporting (reporting bias) Unclear risk No information provided.
Carter 2006
Methods Randomised parallel controlled trial.
Participants Caregivers: 30 American male and female (n = 19) caregivers. Participants identified
themselves as family caregivers living with patient and reported difficulty with initiating
or maintaining sleep or having non-restorative sleep for at least one month. Mean age in
intervention group 52 years (SD 16) and in control group 55 (SD 18). Seventeen were
spouse/partners (10 of these were in the intervention group), 9 were adult children
Mean years in education in the intervention group was 16 (SD 3) and 15 (SD 4) in the
control group. 87% in the intervention group and 73% in the control were Caucasian,
20% in the control group were African American, no African Americans were in the
intervention group. Mean hours caregiving per day in the intervention group were 17
(SD 6) and in the control group 17 (SD 8). Caregivers were excluded if they reported
being diagnosed with a major depressive disorder and/or a preexisting sleep disorder
other than insomnia
Patients: advanced cancer and rated one symptom as severe or daily, at least two symptoms
as moderate or at least three symptoms as mild. Additionally, patient were expected (the
study does not report from whose point of view this is) to live no longer than six months
Interventions Directed at the caregiver.
Aim: To evaluate whether behavioural interventions that support caregivers’ restful sleep
may delay the onset of, or decrease, emotional distress
Interventionists: nurses.
Duration: Two hour sessions.
Content: The Brief Behavioural Sleep Intervention was developed specifically for the
study. It incorporated aspects on stimulus control i.e. how the environment affects sleep,
relaxation therapies, cognitive therapy, and also sleep hygiene i.e. planning of a good
night’s sleep. The first session involved guiding participants in self-assessment of mal-
adaptive habits affecting their sleep, and assisting them to develop personal sleep and
relaxation goals. The second session reviewed attainment goals
Standardisation: The intervention was detailed in a protocol
Comparison group received two sessions on information and training about body me-
chanics such as back health
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Carter 2006 (Continued)
Outcomes Caregiver: Pittsburgh Sleep Quality Index, the Actigraph Sleep Watch, depression mea-
sured using the CES-D, and the Caregiver Quality-of-Life Index-Cancer. Outcomes
evaluated at 3 and 5 weeks, and at 2 (first after intervention) and 4 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk Outcome assessor: No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 5 participants were lost to follow-up (4 as patient
died and 1 because of patient’s declining health)
the authors do not state what group they were
enrolled in. The authors do not state any re-
inclusions in analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
Hudson 2005
Methods Randomised parallel controlled two centre trial.
Participants Caregviers: 106 Australian family caregivers (primary family caregivers were identified
by the patients) aged over 18 years residing with the care recipient. 54 caregivers received
the intervention, 52 received standard care
Mean age of caregivers who completed study was 60.78 years (SD 13.98). 34.9% were
male; 66.7% spouse, 16% adult child, 7.6% parent. 72% of caregivers rated their health
as ’good’ or ’very good’. 32% of caregivers had a professional or university degree. The
mean number of weeks caregivers had been caregiving was 16.3 weeks (SD 5.0)
Patients: Advanced cancer (does not define ’advanced’ any further) admitted to a com-
munity home-based palliative care service. The patient needed to be capable of minimal
self care, and up and about more than 50% of waking hours. 54% of patients were
female, 48% were rated as having limited self care and confined to a bed or a chair more
than 50% of the time, 11% were considered to be completely disabled and confined to
a bed or chair all of the time. 43% had at least three friends/family members assisting
them to provide care
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Hudson 2005 (Continued)
Interventions Directed at caregiver.
Aim: To evaluate the effectiveness of the intervention in enhancing the support and
guidance offered to caregivers
Interventionist: Nurse.
Duration: The intervention involved two home visits and one follow-up phone call
between the visits. It was supported by a caregiver guidebook and audiotape
Content: (1) provision of an opportunity to access information to enhance their under-
standing of issues and provide a basis for skill acquisition, (2) reinforcement of the role
of the palliative care service and other services, and providing strategies to involve family
and friends, (3) helping the caregiver make a sense of/find meaning by normalising emo-
tional reactions to the situation and encouraging caregivers to see the positive aspects of
experience and offering access to spiritual guidance, (4) promoting caregivers to enhance
their own physical and mental health by taking regular time out, having a healthy diet,
taking exercise and providing advice on relaxation strategies and (5) providing advice on
their rights
Standardisation: No details provided.
Comparison group: The patients in the comparison group and intervention received
standard care from the community home based palliative care service. This included 24
hour phone advice with, if needed, emergency visits from a nurse, in addition to pre-
scheduled home visits from nurses, social workers, medical consultants, pastoral care
workers, volunteers and bereavement counsellors
Outcomes Caregiver:
Coping resources
1. Preparedness for Care-giving Scale 8 item scale that assessed how ready caregivers
perceive they are for their role.
2. Caregiver Competence Scale 4 item scale, this assessed perceived adequacy as a
caregiver.
3. 11 items from the Rewards of Care-giving Scale, this assessed perceived potential
benefits or positive aspects associated with being a caregiver.
4. Mastery, using one scale from the caregiving appraisal instrument (6 of the 12
items in scale used), which they defined as how much control a person perceives they
have over an event.
Psychological distress using the Hospital Anxiety and Depression Scale (14 item scale)
Apprisal of role using Self Efficacy Instrument by Zeiss: this relates to people’s belief
that they can initiate courses of action to change. It has 2 sub-scales: 1) caregiver self-
care efficacy, on behaviours caregivers could initiate or participate in, intended to reduce
stress and heighten wellbeing (e.g., social activities,hobbies, and rest), and 2) problem-
solving self-care behaviours
Data were collected at baseline, five weeks later (after the intervention) and eight weeks
after the patient’s death. All outcomes were assessed by self-reported questionnaire
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Hudson 2005 (Continued)
Random sequence generation (selection
bias)
Low risk Generated via computer software.
Allocation concealment (selection bias) Low risk ’the principal investigator provided a par-
ticipant identification number to an inde-
pendent person to facilitate random alloca-
tion’
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk Outcome assessor: No information pro-
vided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 20/54 in intervention group and 25/52
in control completed final follow-up, of
which 15 control and 12 intervention par-
ticipants completed assessments at all three
time points. The authors do not provide
reasons for loss of participants or state any
re-inclusions in analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
Kane 1984
Methods Randomised parallel controlled trial. The allocation to groups was weighted in favour
of hospice care
Participants Caregiver: When patients agreed to participate they were asked to identify a significant
other (SO)whowas then invited to participate. The SOwas commonly a relative, around
half were spouses. Over 80%were female. Does not provided detail on SO’s involvement
in care of patient
Patient: 246/263 terminally ill Amercian veteran patients with a cancer and having a
terminal prognosis of 2 weeks to 6 months. The most common cancer was lung cancer
(34%). Other cancers were colorectal, prostate, ear, nose and throat, brain, bladder and
stomach. The mean age of hospice patients was 63.3 years and in the control group 64
years. More than 97% of patients were men. 59% in the hospice group were white and
64% in the control group were white
Interventions Directed at the patient.
Aim: to evaluate the effectiveness of hospice care.
Interventionists: Multidisplinary team.
Duration: No details provided.
Content: Hospital-based hospice care included: (1) a 11 bed inpatient unit staffed by two
physicians, 19 nurses, a social worker, a chaplain and approximately 30 volunteers; (2)
a home-based program which served approximately 25 patients and (3) a consultation
service for hospice eligible patients in other hospital services. The hospital unit had a
higher staffing ratio than the rest of the general hospital wards
Standardisation: The intervention was not manualised.
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Kane 1984 (Continued)
Comparison group: Patients received the standard treatment plan developed before study
entry
Outcomes Patient and caregiver outcomes:
1. Satisfaction with care assessed by Interpersonal Care Satisfaction Scale adapted
from the Ware Satisfaction Scale, Physical Environment Scale Satisfaction Scale
adapted from McCaffree and Harkins Satisfaction with Nursing Home Scale and
questions on the degree of satisfaction with involvement in care adapted from the
National Cancer Institute’s Hospice Study.
2. Depression measured using 16 of the 20 items from the National Institute of
Mental Health’s Center for Epidemiologic Studies Depression Scale.
3. Anxiety measured using a 5-item sub-scale from the Ware General Well-Being
Measure.
Patient only: Absence of pain and the intensity of pain using symptom scale adapted
from the Califormia Pain Assessment Profile
Measured to 22 weeks from baseline (until patient’s death or until a pre-established
number of interviews had been conducted)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Unclear risk No information provided.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk Outcome assessor: No information pro-
vided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 10/246 patients dropped out during the
course, 6% of caregivers dropped out. The
authors do not provide reasons for loss of
participants or state any re-inclusions in
analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
Keefe 2005
Methods Randomised parallel controlled trial.
Participants Caregiver: American, n = 78, 76% spouse and 14% daughters, mean age 58.5 years,
62% female, 79% white, 20% African American. Does not provide details on level of
caregiving
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Keefe 2005 (Continued)
Patient: From hospices and medical clinics, advanced (defined as metastatic or dissemi-
nated disease) cancer patients with disease-related pain. Life expectancy of less than six
months, and had no change in planned treatment. Most frequent diagnoses were lung,
breast and prostate cancer. Mean age 60.5 years, 44% female, 78% white and 21% Afri-
cian American
Interventions Directed at spouse/partner.
Aim: To test the feasibility of intervention in managing pain, effect on quality of life and
wellbeing
Interventionist: nurse.
Duration: Three face-to-face home sessions of 45 to 60 minutes over one to two weeks
Content: Partner-guided cancer pain management. Nurse educator conducted the ses-
sions with the patient and partner on coping with pain, including types of pain, treat-
ment including relaxation training and imagery and activity pacing method, and com-
munication with health providers. The intervention was supported by a videotape and
book
Standardisation: The treatment was manualised and, for the purpose of supervision
sessions, was audio-taped
Comparison group: Patients received usual care through their medical outpatient or
hospice programme
Outcomes Caregiver: Patients’ self-efficacy in pain management using a caregiver version of the
Chronic Pain Self-Efficacy Scale (5 items). Caregiver strain using the caregiver strain
index (13 items). Positive and negative mood measured using the condensed version of
the Profile of Mood States-B
Patient: Pain measures to assess usual and worse pain using the Brief Pain Inventory.
Quality of life assessed using the Functional Assessment of Cancer Therapy-General
version 4, two sub-scales used on physical wellbeing and social/family wellbeing
None declared a primary outcome.
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ’generated by an individual who was not in-
volved in the study using a random number ta-
ble’
Allocation concealment (selection bias) Unclear risk ’concealed in envelopes that were not opened
until the patient/partner was randomised’
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Outcome assessor: ’the research assistant collect-
ing evaluation data was kept blind with regard
to patient treatment group assignment’
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Incomplete outcome data (attrition bias)
All outcomes
Low risk 22/78 randomised did not complete study.
These were 13 in intervention group (of whom
8 died, 2 were too ill and 3 were lost to follow-
up) and 9 in control group (of whom 4 died, 2
were too ill and 1 dropped out)
Selective reporting (reporting bias) Unclear risk No information provided.
Kissane 2006
Methods Multi-centre cluster randomised parallel controlled trial. Five research sites: two sites
were clinics in palliative care centres withinMelbourneUniversity, and three were hospice
home services. Randomisation by family
Participants Caregiver: from the Australian population. 53 families (n = 233) were randomised to
grief therapy and 28 (n = 130) to control; giving a total number of 363 individuals
randomised. Only families at risk of poor psychosocial outcome were eligible. This
was assessed using the Family Relationship Index. In the final study cohort, 51% of
families were classified as having family intermediate functioning, 26% were designated
as sullen and 23% as hostile. Hostile families were defined as tending to reject help and
are distinguished by high family conflict levels, poor cohesion and poor expressiveness.
Sullen families were defined as moderately impaired across three domains that define
hostile families. Intermediate functioning families were those that exhibited moderate
cohesiveness but are prone to psychosocial morbidity. The study provided no detail on
family caregiving of patient. The mean age of the patient’s spouse was 56 years (SD 9)
and for their offspring it was 29 years (SD 9). There were slightly more female caregivers
thanmale (96/180). Most participants were either of professional or clerical occupational
group (123/189)
Patient: Cancer patients given a prognosis of six months by treating physician, had a
living partner and one or more children more than 12 years old. The most common
cancer was breast (25%) and lung (20%). The mean age was 57 years (SD 8)
Interventions Directed at the family.
Aim: To evaluate whether grief therapy reduced themorbid effects of grief among families
at risk of poor outcomes
Interventionist: Social workers who were qualified family therapists
Duration: Started during palliative care and continued into bereavement. It comprised
of 4 to 8 sessions of 90 minutes duration, across 9 to 18 months
Content: The family focused grief therapy intervention aimed to enhance the func-
tioning of the family to prevent complications of bereavement. It was operationalised
through exploring family cohesion, communication of thoughts and feelings, and han-
dling of conflict. In the process it was envisaged that the personal story of the illness
and related grief would be shared. There were three intervention phases: ascertainment
which involved identifying concerns relevant to the specific family, devising and acting
on a plan to deal with concerns and, at the end of the therapy, consolidation of what was
gains and was confronted during the therapy
The therapy was conducted either in the hospital or, more commonly, at home
Standardisation: Documented in a manual. This was published in a book as a series of
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Kissane 2006 (Continued)
guidelines. The social workers received training to conduct the intervention. Fidelity to
the intervention was assessed independently
Comparison group: Families received standard home care palliative care; counselling was
included where needed
Outcomes Caregiver: The primary outcome was psychosocial functioning in bereaved family mem-
bers, particularly levels of distress, depression and social adjustment
Family function was measured using two scales. These were items from the 40-item
Family Environment Scale and from the 60-item Family Assessment Device
Psychological morbidity was measured using two scales: the Brief Symptom Inventory
and the cognitive items from theBeckDepression Inventory. To differentiate normal grief
expressions frommoremorbid forms of distress and depression, the 22-itemBereavement
Phenomenology Questionniare was used
The Social Adjustment Scale was used to measure social functioning including house-
work, work, social and leisure activities, relationships with children and extended family
and overall functioning
Outcomes were evaluated at 6 and 13 months after the patient’s death
Notes The study was adjusted for clustered data analysis.
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation was performed indepen-
dently using a computer generated table of
random numbers, to make the allocation
in the 2:1 ratio, stratifying by recruitment
site
Allocation concealment (selection bias) Low risk Randomisation was performed indepen-
dently.
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk Outcome assessor: No information pro-
vided.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 64/81 families that consented to take part
received the treatment they were allocated
to receive and completed the trial. Two
families that dropped out early did so as
they were dissatisfied with intervention,
does not provide reasons for other fami-
lies not completing, or information on trial
arm allocation
The effect of missing data was assessed by
examining differences at baseline between
those with missing outcome data and com-
plete outcome data, then the authors com-
38Interventions for supporting informal caregivers of patients in the terminal phase of a disease (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Kissane 2006 (Continued)
pared whether these differences were the
same for the treatment and control groups.
Participants with missing data had signifi-
cantly poorer family functioning according
to baseline score on the family assessment
scales, however these did not differ signifi-
cantly between the treatment groups
Analysis was on an intention-to-treat ba-
sis; the authors analysed patients according
to which treatment group they were ran-
domised to, irrespective of whether or not
they received that treatment
Selective reporting (reporting bias) Unclear risk No information provided.
McMillan 2005
Methods Randomised parallel controlled trial. Three armed trial.
Participants Caregivers: 329 American family caregivers providing care for adult patients with cancer.
All were recruited from an organisation providing hospice care in the community. Does
not state cancer stage of patients
In the COPE intervention group caregiver mean age was 63 years (SD 13.58), 77%
were female and mean years in education was 13.06 (SD 2.98). In the group that had
supportive visits the mean age was 61 years (SD 15.47), 99% were female and mean
years in education was 12.70 (SD 2.40). In the standard care group the mean age was 60
years (SD 15.27), 81% were female and mean years in education was 12.86 (SD 2.25).
The mean age of patients was 70 years (SD 12.58), 44% were female and mean years in
education was 12.49 (SD 2.80). No details were provided on the extent of caregiving
Patient: In the intervention group the mean age was 71 years (SD 10.99) and 37% were
female. Mean years in education was 11.84 (SD 3.41). In the supportive group mean
age was 71 years (SD 12.12), 38% were female and mean years in was education 12.28
(SD 3.21)
Interventions Intervention directed at caregiver.
Aim: To determine whether hospice plus a coping skills training intervention improved
quality of life and coping
Interventionist: nurse.
Duration: Three supportive visits.
Content: Standard hospice care plus coping skills intervention was delivered by nurses,
it involved 1:1 teaching of problem-solving methods that aimed to assist caregivers with
assessing and managing patient symptoms. It was composed of 4 components:
1. creativity, defined as viewing problems from a different perspective and
developing new strategies for solving caregiving problems;
2. optimism, defined as having a positive but realistic attitude toward problem
solving;
3. planning, which involved setting reasonable caregiving goals and the steps
necessary to reach these goals; and
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4. the provision of lay information about the nature of the problem.
Standardisation: Documented in a manual and audiotapes of interventions were re-
viewed. The nurses were provided with training to delivered the intervention. The fi-
delity of the intervention was monitored
Comparison groups:
Comparison 1: Standard hospice care plus a coping skills intervention (n = 111); arm 2:
standard hospice care plus 3 supportive visits (n = 109) from intervention nurse; arm 3:
standard hospice care (n = 109)
Comparison 2: Attention control of standard hospice care plus supportive visits involved
the nurse discussing with the caregiver their feelings, fears and relationships with their
loved one dying from cancer. The nurse did not give advice to caregivers about managing
problems and did not teach any structural problem-solving skills
Delivery of attention control and intervention took the same time
Description of standard hospice care not provided.
Outcomes Caregiver.
Primary outcome measures
Quality of life using the 35-item Quality-of-Life Index-Cancer (CQOL-C)
General caregiver mastery using a 6-item validated scale.
Burden andmastery specific to care giving tasks wasmeasured used the 46-itemCaregiver
Demands Scale
Burden of cancer symptoms was assessed using the 24-item Memorial Symptoms As-
sessment Scale
Secondary outcomes
Coping responses to intervention was measured using the 28-item Brief COPE scale
Outcomes assessed at 16 (one week post intervention) and 30 days
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk ’Computerised randomisation procedure
by telephone’.
Allocation concealment (selection bias) Low risk ’Computerised randomisation procedure
by telephone’.
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk The data collectors were blind to subjects’
group assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk Number of participants that dropped out
before the study finished was 63% in con-
trol group and 71% in support group, and
72% in coping group. Most commonly at-
trition was due to patient decline in health,
or death, or caregiver feeling overwhelmed.
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More younger caregivers dropped out. The
authors do not state any re-inclusions in
analyses performed. All individuals who
contributed any data were included in
the random effects model (main analysis)
. Those who completed follow-up were
compared to those who did not on a wide
range of outcomes
Selective reporting (reporting bias) Unclear risk No information provided.
Northouse 2005
Methods Randomised parallel controlled trial. Groups were stratified by treatment
Participants 182 American families. 88 families assigned to comparison group
Caregiver: Primary caregiver, either a family member or a significant other who was
identified by the patient as her primary source of emotional and physical support during
the recurrent phase of breast cancer and confirmed by the designated individual. Both
patient and caregivers were eligible only if aged 21 years or older. Mean age 52 years (SD
14), 62% of family members were husbands, the remaining were siblings (9%), adult
daughters (13%), adult sons (3%) or other relatives or friends (13%). Does not provide
details on extent of caregiving
Patient: Recurrent breast cancer defined as cancer that had progressed within previous
month confirmed by clinical tests and that this necessitated change in treatment although
life expectancy was at least 6 months. Patients with stage 3 (cancer spread beyond the
breast such as lymph nodes or chest wall) and stage 4 (cancer spread to other organs)
breast cancer were included in analysis only (n = 182). Mean age 54 years (SD 11)
Despite randomisation, group differences emerged the control group patients at baseline
had significantly less negative appraisal of illness and less hopelessness than intervention
patients; these aspects were controlled for in subsequent analysis
Interventions Intervention directed at the family.
Aim: To explore whether the intervention facilitate support and their communication
Interventionist: nurse.
Duration: Threemonthly home visits with the patient and her family. Visits were around
1.5 hours long. During the booster phase the nurse made two prearranged follow-up
phone calls, these were around 30 minutes each
Content: The FOCUS program provided patients and their family information and
support. It involved 5 contacts, and had 5 main components; specifically, promoting
a cohesive family, encouraging an optimistic attitude, helping them to cope effectively,
provision of information to help reduce uncertainty and to assist them in symptom
management
94 patients were assigned to intervention group. Components of the intervention were
based on a literature review
Standardisation: A protocol manual outlined the interventions for each home visit and
phone calls, although some flexibility of the intervention was permitted based on indi-
vidual needs
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Comparison group: No details provided on what usual care group received
Outcomes Caregiver and patient.
Quality of life was measured using two scales: the FACT scale version three and the SF-
36 Health Survey
Coping was measured using the 24-item Brief COPE. The scale assesses 12 coping strate-
gies: self-distraction, active coping, denial, alcohol/drug use, emotional support, behav-
ioral disengagement, venting, positive re framing, planning, use of humor, acceptance,
and religion
Hopelessness was measured using the 20-item Beck Hopelessness Scale; uncertainty was
measured by the 28-item community version for patients and the 29-item family version
for caregivers of the Mishel Uncertainty in Illness Scale
Patients’ appraisal of illness was measured with the 27-item Appraisal of Illness Scale and
caregivers’ with the 27-item Appraisal of Caregiving scale
All outcomes were assessed for both caregivers and patients. Follow-up was at 3 months
(after home visit phase) and 6 months (after booster phone calls)
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used lists generated by random numbers.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk The data collectors were blind to subjects’
group assignment
Incomplete outcome data (attrition bias)
All outcomes
Low risk 134/182 completed follow-up assessments
(these were 69 in intervention and 65 in
control group), of those lost to follow-up
38/48 died, 5 refused to continue, 2 were
too ill, 2 caregiver and patient relationship
ended and 1 was unable to be contacted.
Patients lost to follow-up had significantly
shorter disease free intervals, more uncer-
tainty about the illness and more symp-
toms. There was no difference in loss, or
reasons for loss, to follow-up between inter-
vention and control groups (intervention
lost n = 25, control lost n = 25). The au-
thors do not state any re-inclusions in anal-
yses performed
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Selective reporting (reporting bias) Unclear risk No information provided.
Northouse 2007
Methods Randomised parallel controlled trial.
Participants 263American patient-spouse couples. 84%of couples were Caucasian, 14%were African
American. Patient and spouses reported averages of 16 and 15 years of formal education,
respectively
Caregiver: Spouse/partners were eligIble if they were aged over 21 years and were iden-
tified by patients as their primary caregiver. Mean age 59 years (SD 9.7 years). 25% had
heath problems, such as arthritis or back pain. No information provided on the extent
of caregiving
Patient: In one of three phases of prostate cancer (i.e. newly diagnosed, biochemical
recurrence or advanced). Patient were aged over 30 years, with a life expectancy of more
than 12 months, with a spouse or live-in partner. Mean age 63 years (SD 9.1), 21% were
in the advanced phase of prostate cancer
Interventions Intervention directed at patient-spouse couples.
Aim: The hypothesis was that couples that received the intervention would report fewer
negative outcomes on appraisal variables, more positive outcomes on coping and have a
higher quality of life
Interventionist: Nurse.
Duration: The four month programme consisted of three 90 minute home visits and
two 30 minute telephone sessions which were 2 weeks apart
Content: Received standard clinic care plus the FOCUS program. This was a modified
intervention tested initially on breast cancer patients and their family caregivers (See
Northouse 2005). The content involved encouraging couples to work as a team, promot-
ing an optimistic attitude to maintain hope which involved focusing on achievable short
term goals, coping strategies that aimed to reduce stress, reducing uncertainty by proving
information and ways to live with uncertainty, and support with symptom management
Standardisation: Interventionist had a training video and a protocol checklist outlining
the intervention, although the intervention allowed tailoring of topics to the needs of
the individual couple
Comparison group: Patients received standard clinic care at their cancer treatment centre.
The clinic addressed primarily diagnosis and treatment of patients’ disease; there were
no specific psychosocial resources targeted at the couples
Outcomes Caregiver and patient.
Quality of life of patient and spouse assessed using theMedical Outcomes Study 12-item
short form and a cancer specific measure, the general Functional Assessment of Cancer
Treatment (FACT-G) 27-item. In addition patients completed FACT-P a prostate-spe-
cific QOL scale
Illness and caregiving appraisals were assessed with the 27-item Appraisal of Illness or
Appraisal of Care-giving Scales. This measures patients’ level of threat associated with
the illness as well as the spouse’s perception of caregiving. Uncertainty was measured
using the 28-item Mishel Uncertainty in Illness Scale, and hopelessness using the 20-
item Beck Hopelessness Scale
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Coping strategies were assessed using the 28-item Brief Coping Orientations to Problems
Experienced scale, self-efficacy using the 17-item Lewis Cancer Self-Efficacy Scale (mea-
sures confidence in managing stress and changes associated with cancer or treatments)
and communication using the 32-item Lewis Mutuality and Interpersonal Sensitvity
Scale
Symptom distress using the 16-item Symptom Scale of the Omega Screening Question-
naire of which both the patient and spouses rated how much they were experiencing
symptoms such as fatigue and sleeping problems. The 50-item Expanded Prostate Can-
cer Index Composite (EPIC) measured specific prostate symptoms. Spouses completed
the 4-item spousal version of the EPIC, this assess the extent to which husbands’ prostate
specific symptoms created problems for the spouses
The risk of developing future emotional distress was measured at baseline only, using
the 77-item Omega Clinical Screening Interview
None declared primary outcome.
Outcomes assessed at 4 (end of intervention), 8 and 12 months
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Used lists generated by random numbers.
Allocation concealment (selection bias) Unclear risk No information provided.
Blinding (performance bias and detection
bias)
Outcome assessor
Low risk Data collection nurses were blinded to group
assignment.
Incomplete outcome data (attrition bias)
All outcomes
Low risk 218/263 couples completed all 3 follow-up as-
sessments. Among the 45 couples that did not
complete the study, reasons included patient
death (n = 15), 9 declined intervention, and 6
were too busy. There was no significant differ-
ences between groups in terms of the number
of follow-up visits, number of lost to follow-up,
number completing all assessments or numbers
lost for other reasons. The authors do not state
any re-inclusions in analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
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Methods Randomised parallel controlled trial.
Participants Caregiver: 271 British male and female (n = 215) primary caregivers who scored over 5/
6 on the 28-item General Health Questionnaire (GHQ-28)
Intervention group n = 137, male and female (n = 108) caregivers, mean age 56.4 years
(SD 14.6), spouse/partner 92/137, adult child 29/137, received tertiary education 38/
137, white ethnic group 114/137, socioeconomic groups 1,2 n = 92/137(using the 3
socio-economic class system for theUKoffice ofNational statistics.Group 1 =managerial
and professional occupations, group 2 = intermediate occupations, and group = 3 routine
and manual occupations)
Comparison group n = 134, male and female (n = 107) caregivers, mean age 56.1 years
(SD 13.2), adult child 38/134, spouse/partner 80/134, received tertiary education 45/
134, white ethnic group 118/134, Socio-economic groups 1,2 n = 93/134
Does not report details on caregiving, but reports caregiver strain using the Caregiver
Strain Index
Patient: In intervention group, diagnosis was lung cancer n = 32, gastrointestinal cancer
n = 23, genitourinary cancer n = 27, head and neck cancer n = 15, breast cancer n =
6, and other cancers n = 34. Time since diagnosis was a median 8 months (range 2 to
75.6 months). The time to death in weeks was a median of 13 (range 2 to 41.1 weeks).
In comparison group, diagnosis was lung cancer n = 47, gastrointestinal cancer n = 32,
genitourinary cancer n = 13, head and neck cancer n = 9, breast cancer n = 12, and other
cancers n = 21. Time since diagnosis was a median 4 months (range 1 to 89.5 months).
The time to death in weeks was a median of 11 (range 1 to 39.6 weeks)
Interventions Intervention directed at the caregiver.
Aim: evaluatIon of the effectiveness of increased support for distressed, informal care-
givers of patients receiving palliative care
Interventionist: trained advisors, one experienced in community nursing and one expe-
rienced in social work
Duration: Six weekly sessions.
Content: The advisors aimed to meet the caregiver alone, although sometimes they were
replaced with telephone calls. A needs assessment was conducted, and information and
emotional support provided. Topics covered at each session were patient care, caregiver
physical health needs, need for time away from the patient in the short-term and longer
term, need to plan for the future, psychological health, relationships and social networks,
contact with health and social services providers and their personal finances
Standardisation: No information provided.
Comparison group: Involved specialist palliative care provided by a team of clinical nurse
specialists who had specialist medical support. It also sometimes involved social work
support. Patients were assisted with control of pain and other physical symptoms as well
as with social, psychological, emotional and spiritual issues
Outcomes Caregiver outcome.
The primary outcome measure was caregiver’s psychological distress using the GHQ-28,
with the proportion of patients scoring over 5/6. [MP: Unclear]
Secondary outcomes were GHQ-28 score, caregiver strain (the Carer Strain Index), and
quality of life (Caregiver Quality-of Life-Index)
Outcomes were assessed via self report using a postal questionnaire
All outcomes were assessed at 4, 9 (first follow-up after intervention) and 12 weeks and
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there was a follow-up 4 months after the patient’s death
Satisfaction with care and scores on the Core Bereavement Items were assessed at 4
months after the patient’s death. A brief, semi-structured interview at the final follow-
up was undertaken to assess acceptability and helpfulness of the support provided by the
intervention
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Randomisation sequence using computer gener-
ated table. Block randomisation (block size 12)
and stratified according to study teams
Allocation concealment (selection bias) Low risk ’took place at the trial centre under the supervi-
sion of the trial statistician’
Blinding (performance bias and detection
bias)
Outcome assessor
Unclear risk No information provided.
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk 134 were randomised to control group; of these
62 patients died, 54/72 remaining responded to
final follow-up at 12 weeks
137 were randomised to intervention group;
of these 47 patients died, 69/90 remaining re-
sponded to final follow-up
The authors do not state any re-inclusions in
analyses performed
Selective reporting (reporting bias) Unclear risk No information provided.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Belasco 2000 Review on interventions in supportive care
Black 1991 Intervention delivered in bereavement only
Brodaty 1991 Not advanced disease and no caregiver outcomes
Buick 2000 No caregiver outcomes
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Chan 2004 No caregiver outcomes
Christakis 2003 Not an experimental study
Clark 2006 Patients not in the terminal phase of a disease
Clayton 2007 No caregiver outcomes
Collinge 2007 Does not state patients are in the terminal phase of a disease
Demiris 2005 Not an evaluative study
Dobrof 2006 Not a controlled evaluation
Gaugler 2003 Does not state patients are in the terminal phase of a disease
Gavrilova 2008 Patients not in the terminal phase of a disease
Goelitz 2003 Not a controlled evaluation
Grand 2004 Secondary analysis of trial data
Haggmark 1987 Inappropriate control
Harding 2004 Inappropriate control
Hays 2006 Not an evaluative study
Henrich 1985 Patients unlikely to be in end stage
Hudson 2008 Not a controlled evaluation
Jepson 1999 Patient not in the terminal phase of a disease
Kirk 2006 No caregiver outcomes
Kissane 2004 No caregiver outcomes
Kurtz 2005 Patients not in the terminal phase of a disease
Low 2008 Not a primary evaluation
Mason 2007 Systematic review of evidence
McCorkle 1998 Study was a secondary analysis of an RCT
McDonald 2006 Not a controlled evaluation
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McMillan 2007 No caregiver outcomes
McMillian 1994 Not an experimental study
Murray 2004 Not an evaluative study
Nurock 2007 No caregiver outcomes
Smeenk 1998 Quasi-experimental design
Toseland 1995 Does not state patients are in the terminal phase of a disease
Characteristics of ongoing studies [ordered by study ID]
Fegg 2009
Trial name or title Supportive group psychotherapy for relatives of palliative care patients: a randomised controlled prevention
study
Methods Randomised controlled trial
Participants Relatives of palliative care patients in Germany
Interventions Supportive group psychotherapy
Outcomes
Starting date
Contact information Dr Martin Fegg praxis@psychotherapeut-muenchen.de
Notes Plan to finish October 2010
O’Hara 2010
Trial name or title Randomised controlled trial of ENABLE
Methods Randomised controlled trial. Two trial arms intervention
Participants 322 American male and female (n = 135) patients with advanced cancer from a single rural cancer centre. A
proportion of the patients identified someone close to them that was involved in their care
Intervention group n = 161male and female (n = 70) patients, mean age 64.7 years (SD 10.8), received tertiary
education 17/161, white ethnic group 143/161. Patient diagnosis was lung cancer n = 59, gastrointestinal
cancer n = 64, genitourinary cancer n = 19, breast cancer n = 17. No details on caregivers
Control group n = 161 male and female (n = 65) patients, mean age 65.4 years (SD 11.6), received tertiary
education 20/161, white ethnic group 132/161. Patient diagnosis was lung cancer n = 58, gastrointestinal
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cancer n = 67, genitourinary cancer n = 20, breast cancer n = 16. No details on caregivers
Does not report details on caregiving.
Interventions Intervention, ENABLE, provided to patient that aim to provide education, emotional support and advice.
This was a manualised telephone intervention. One of two advanced practice nurses with palliative care
training held 4 education and problem solving sessions. This was followed by telephone sessions at least
monthly
Comparison group: Involved use of all oncology, supportive services and palliative care service
The intervention was reported in a manual.
Outcomes Caregivers self reported burden using the Montgomery-Borgatta Caregiver Burden Scale measured at one
month and every three months until the patients death
Patient outcomes: self reported quality of life, symptom intensity and resource use
Starting date Trial completed, write up of evidence on caregiver outcomes underway
Contact information Marie.A.Bakitas@hitchcock.org
Notes
49Interventions for supporting informal caregivers of patients in the terminal phase of a disease (Review)
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
D A T A A N D A N A L Y S E S
Comparison 1. Direct Interventions: Primary outcome at end of intervention - Psychological health
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Psychological distress 8 936 Std. Mean Difference (IV, Random, 95% CI) -0.15 [-0.28, -0.02]
2 Coping with the caring role 7 738 Std. Mean Difference (IV, Random, 95% CI) -0.05 [-0.24, 0.14]
3 Quality of life 6 631 Std. Mean Difference (IV, Random, 95% CI) 0.08 [-0.11, 0.26]
Analysis 1.1. Comparison 1 Direct Interventions: Primary outcome at end of intervention - Psychological
health, Outcome 1 Psychological distress.
Review: Interventions for supporting informal caregivers of patients in the terminal phase of a disease
Comparison: 1 Direct Interventions: Primary outcome at end of intervention - Psychological health
Outcome: 1 Psychological distress
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allen 2008 10 13.45 (8.38) 12 12.58 (9.41) 2.4 % 0.09 [ -0.75, 0.93 ]
Carter 2006 15 12.8 (9) 15 12 (12) 3.3 % 0.07 [ -0.64, 0.79 ]
Keefe 2005 28 0.84 (0.75) 28 1.16 (0.75) 6.0 % -0.42 [ -0.95, 0.11 ]
Hudson 2005 40 7.76 (3.56) 35 8.06 (3.95) 8.2 % -0.08 [ -0.53, 0.37 ]
Walsh 2007 70 9.3 (6.5) 64 10.7 (7.3) 14.5 % -0.20 [ -0.54, 0.14 ]
Northouse 2005 69 2.95 (3.7) 65 3.83 (5.01) 14.6 % -0.20 [ -0.54, 0.14 ]
Northouse 2007 112 2.47 (2.1) 123 3.07 (2.4) 25.4 % -0.26 [ -0.52, -0.01 ]
Kissane 2006 156 0.4416 (0.4468) 94 0.44 (0.444) 25.7 % 0.00 [ -0.26, 0.25 ]
Total (95% CI) 500 436 100.0 % -0.15 [ -0.28, -0.02 ]
Heterogeneity: Tau2 = 0.0; Chi2 = 3.97, df = 7 (P = 0.78); I2 =0.0%
Test for overall effect: Z = 2.32 (P = 0.020)
Test for subgroup differences: Not applicable
-1 -0.5 0 0.5 1
Favours experimental Favours control
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Analysis 1.2. Comparison 1 Direct Interventions: Primary outcome at end of intervention - Psychological
health, Outcome 2 Coping with the caring role.
Review: Interventions for supporting informal caregivers of patients in the terminal phase of a disease
Comparison: 1 Direct Interventions: Primary outcome at end of intervention - Psychological health
Outcome: 2 Coping with the caring role
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allen 2008 17 48.94 (6.82) 14 46.57 (7.1) 5.9 % 0.33 [ -0.38, 1.05 ]
Hudson 2005 40 -8.29 (1.5) 35 -8.22 (2.5) 12.3 % -0.03 [ -0.49, 0.42 ]
Keefe 2005 28 6.19 (2.21) 28 7.33 (2.21) 9.6 % -0.51 [ -1.04, 0.02 ]
McMillan 2005 31 27.19 (2.92) 40 26.6 (2.77) 11.6 % 0.21 [ -0.26, 0.68 ]
Northouse 2005 69 70.13 (15.2) 65 70.52 (15.2) 18.1 % -0.03 [ -0.36, 0.31 ]
Northouse 2007 112 -144.1 (17.8) 123 -138.8 (22.3) 24.3 % -0.26 [ -0.52, 0.00 ]
Walsh 2007 73 26.7 (11.4) 63 25.1 (10.1) 18.2 % 0.15 [ -0.19, 0.48 ]
Total (95% CI) 370 368 100.0 % -0.05 [ -0.24, 0.14 ]
Heterogeneity: Tau2 = 0.02; Chi2 = 8.93, df = 6 (P = 0.18); I2 =33%
Test for overall effect: Z = 0.53 (P = 0.59)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Favours experimental Favours control
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Analysis 1.3. Comparison 1 Direct Interventions: Primary outcome at end of intervention - Psychological
health, Outcome 3 Quality of life.
Review: Interventions for supporting informal caregivers of patients in the terminal phase of a disease
Comparison: 1 Direct Interventions: Primary outcome at end of intervention - Psychological health
Outcome: 3 Quality of life
Study or subgroup Experimental Control
Std.
Mean
Difference Weight
Std.
Mean
Difference
N Mean(SD) N Mean(SD) IV,Random,95% CI IV,Random,95% CI
Allen 2008 17 4.18 (0.95) 14 4.5 (9.21) 6.2 % -0.05 [ -0.76, 0.66 ]
Carter 2006 15 -52.3 (19) 15 -48.5 (24) 6.0 % -0.17 [ -0.89, 0.55 ]
McMillan 2005 31 49.55 (24.72) 40 57.5 (18.76) 12.7 % -0.36 [ -0.84, 0.11 ]
Northouse 2005 69 49.59 (9.1) 65 49.07 (9.4) 21.8 % 0.06 [ -0.28, 0.39 ]
Northouse 2007 112 50.9 (7.5) 123 49 (7.5) 32.0 % 0.25 [ 0.00, 0.51 ]
Walsh 2007 71 69.3 (22.7) 59 65.2 (17) 21.1 % 0.20 [ -0.15, 0.55 ]
Total (95% CI) 315 316 100.0 % 0.08 [ -0.11, 0.26 ]
Heterogeneity: Tau2 = 0.01; Chi2 = 6.17, df = 5 (P = 0.29); I2 =19%
Test for overall effect: Z = 0.81 (P = 0.42)
Test for subgroup differences: Not applicable
-0.5 -0.25 0 0.25 0.5
Favours contrl Favours experimental
A D D I T I O N A L T A B L E S
Table 1. Direct intervention: Psychological distress at the end of treatment
Trial, time since baseline and end-of-treatment Outcomes displayed, unless indicated otherwise, as: Intervention mean,
standard deviation (SD), n versus (v) control mean, SD, n.
Allen 2008
One week
Depression 12.58 (9.41) n =10 v 9.17 (6.98) n = 12
Carter 2006
2 months
Depression 12.8 (9) n = 15 v 12 (12) n = 15
Hudson 2005
4 weeks
Anxiety 7.76 (3.56) n = 40 v 8.06 (3.95) n = 35
Keefe 2005
Mean 6 days, (range 0 to 31 days)
Mood negative 0.84 (0.75) n=28 v 1.16 (0.75) n=28
(Analysis adjusted for participants’ pre treatment score)
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Table 1. Direct intervention: Psychological distress at the end of treatment (Continued)
Kissane 2006*
6 months
Psychological morbidity 0.4416 (0.4468) n = 156 v 0.4433 (0.444) n = 94
Depression 3.60 (3.74) n = 154 v 4.21 (4.92) n = 94
Northouse 2005
3 months
Hopelessness 2.95 (3.7) n = 69 v 3.83 (5.01) n = 65
Northouse 2007
4 months
Hopelessness 2.47 (2.1) n = 112 v 3.07 (2.4) n =123
Walsh 2007
9 weeks
Depression 9.3 (6.5) n = 72 v 10.7 (7.3) n = 64
Scores expressed as the lower the better the outcome. See Analysis 1.1, for overall effect size. (In trials with multiple outcomes the median effect
was used in combined trial analysis).
* Most conservative estimate was used in combined analysis.
Table 2. Direct interventions: Psychological distress at the end of follow-up
Trial, time since end of treatment phase Displayed unless stated otherwise as: Intervention mean (SD), n versus (v)
controlmean (SD), n. Standardised mean difference (MD) and [confidence
interval]
Carter 2006
2.5 months
Depression 8.5 (7) n = 15 v 8 (8.5) n = 15 MD 0.06 [95% CI -0.65 to 0.78]
Hudson 2008
At least 8 weeks after patient’s death
Anxiety 6.96 (4.02) n = 20 v 6.76 (3.72) n = 25 MD 0.05 [95% CI -0.54 to 0.
64]
Kissane 2006
13 months
Depression*-0.36 (4.61) n = 148 v -0.10 (4.26) n = 83 MD -0.06 [95% CI -
0.33 to 0.21]
Psychological morbidity* -0.12 (0.48) n = 147 v -0.01 (0.38) n = 83 MD -0.
25 [95% CI -0.52 to 0.02]
Northouse 2005
3 months
Hopelessness 2.62 (3.3) n = 69 v 3.89 (4.6) n = 65 MD -0.32 [95% CI -0.66
to 0.02]
Northouse 2007
8 months
Hopelessness 2.71 (2.2) n = 104 v 3.06 (2.5) n = 114 MD -0.15 [95% CI -0.
41 to 0.12]
Walsh 2007
6 weeks
Depression 11.3 (7.3) n = 69 v 11.7 (7.8) n = 54 MD 0.05 [95% CI -0.41 to
0.30]
Median effect size* 0.05
Number of comparisons showing a positive direction of effect of intervention 5/7
Number of comparisons showing a statistically significant effect 0/7
Scores expressed as the lower the better the outcome.
*Change in mean scores baseline to 13 months
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Table 3. Direct intervention: Coping with the caring role at the end of treatment
Trial, time since baseline Outcomes displayed, unless stated otherwise, as: Intervention mean, standard
deviation (SD), n versus (v) control mean (SD) n. Summary statistics provided
if trial is not included in review analysis
Allen 2008
One week
Caregiver stress 48.94 (6.82) n = 17 v 46.57 (7.10) n = 14
Hudson 2005
4 weeks
Rewarding interaction 8.29 (1.5) v 8.22 (2.5)*
Rewards 3.09 (0.82) v 2.82. (0.99)*
Preparedness 2.76 (0.81) v 2.67 (0.81)*
Problem solving 7.37 (1.92) v 8.14 (1.35)*
Competence 2.37, 0.63 v 2.4 (0.54)*
Respite 6.79 (2.16) v 6.23, 2.67*
All n = 40 v n = 35
Keefe 2005
Mean 6 days, (range 0 to 31 days)
Caregiver strain 6.19 (2.21) v 7.33 (2.21)
Caregiver self-efficacy
For pain 57.90 (17.97) v 43.68 (17.92)*
For other symptoms 66.93 (18.21) v 54.03 (18.20)*
For physical activities 57.20 (23.04) v 63.06 (22.98)*
All n = 28 v n = 28
McMillan 2005
One month
Symptom burden 19.52 (14.84) n = 31 v 22.75 (11.80) n = 40
Care giving task burden 1.95 (.99) n = 31 v 2.49 (.77) n = 40
General Mastery 27.19 (2.92) n = 31 v 26.60 (2.77) n = 40*
Caregiver task mastery 4.31 (.85) n = 31 v 4.11 (.77) n = 40*
Problem focused coping 11.73 (4.56) n = 30 v 11.34 (3.16) n = 38*
Emotion focused coping 16.60 (5.32) n = 30 v 16.84 (4.70) n = 38*
Northouse 2005
3 months
Active coping 5.66 (1.2) v 5.17 (1.3)*
Avoidant coping 3.28 (0.96) v 3.29 (1.0)
Negative appraisal of care-giving 2.50 (0.55) v 2.62 (0.70)
Uncertainty 70.13 (15.2) v 70.52 (15.2)
All n = 69 v n = 65
Northouse 2007
4 months
Active coping 29.9 (5.7) v 29 (5.5)*
Avoidant coping 14.4 (3.1) v 15 (2.9)
Self efficacy 144.1 (17.8) v 138.8 (22.3)*
Negative appraisal of care-giving 2.29 (0.49) v 2.44 (0.46)
Uncertainty 59.5 (12.2) v 63.1 (13.9)
Symptom distress 5.10 (3.4) v 6.28 (3.6)
All n = 112 v n = 123
Walsh 2007
9 weeks
Caregiver strain 26.7 (11.4) n = 73 v 25.1 (10.1) n = 63
Scores expressed as the lower the better the outcome.
*Effect measure reversed as scale in the opposite direction. See Analysis 1.2 for overall effect size. (In trials with multiple outcomes the median
effect was used in combined trial analysis).
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Table 4. Direct interventions: Coping with the caring role at the end of follow-up
Trial, time since end of treatment phase Displayed as: Intervention mean (SD) n versus (v) control mean (SD) n,
standardised mean difference (MD) and [confidence interval]
Hudson 2005
At least 8 weeks after patient’s death
Rewards 3.5 (0.7) n =20 v 3.04 (0.82) n = 25 MD -0.59 [95% CI -1.19 to 0.
01]*
Preparedness 2.83 (0.79), n = 20 v 2.59 (0.88) n = 25) MD -0.28 [95% CI -0.
87 to 0.31]*
Competence 2.53 (0.51) n = 20 v 2.47 (0.48) n = 25 MD -0.12 [95% CI -0.
71 to 0.47]*
Northouse 2005
3 months
Active coping 5.41(1.2) v 5.19 (1.3) MD -0.18 [95% CI -0.51 to 0.16]*
Avoidant coping 3.25 (0.9) v 3.30 (1.0). MD -0.05 [95% CI -0.39 to 0.29]
Negative appraisal of care-giving 2.53 (0.57) v 2.56 (0.68), MD -0.05 [95%
CI -0.39 to 0.29]
Uncertainty 76.19 (12.9) v 78.43 (13.4) MD -0.17 [95% CI -0.51 to 0.17] All
n = 69 v n = 65
Northouse 2007
8 months
Active coping 30.5 (5.5) v 28.9 (6) MD -0.28 [95% CI -0.54 to -0.01]*
Avoidant coping 14.9 (3.1) v 14.9 (2.9) MD 0.00 [95% CI -0.27 to 0.27]
Self-efficacy 143.8 (17.9) v 137.8 (22.6) MD -0.29 [95% CI -0.56 to -0.02]*
Negative appraisal 2.35 (0.51) v 2.39 (0.49) MD -0.08 [95% CI-0.35 to 0.19]
Uncertainty 60.3 (12.5) v 61.1 (13.9) MD -0.06 [95% CI -0.33 to 0.21] All n
= 104 v n = 114
Walsh 2007
6 weeks
Caregiver strain 27.2 (11.7) n = 69 v 27.3 (10.2) n = 54 MD -0.01 [95% CI -
0.37 to 0.35]
Median effect size -0.05
Number of comparisons showing a positive direction of effect of intervention 12/13
Number of comparisons showing a significant effect 2/13 (both favour the intervention)
Scores expressed as the lower the better the outcome *Effect outcome reversed as scale in the opposite direction
Table 5. Direct interventions: Quality of life at the end of treatment
Trial, time since baseline Outcomes displayed unless stated otherwise as: Intervention mean, standard deviation (SD), n
versus (v) control mean (SD) n. Summary statistics provided if trial is not included in review
analysis.
Allen 2008
One week
Subjective wellbeing 4.08 (0.95) n = 17 v 4.50 (9.21) n =14
Carter 2006
2 months
Quality of life (QOL) 52.3 (19) n =15 v 48.5 (24) n = 15*
McMillan 2005
One month
QOL 49.55 (24.72) n = 31 v 57.50 (18.76) n = 40
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Table 5. Direct interventions: Quality of life at the end of treatment (Continued)
Northouse 2005
3 months
Mental QOL 50.46 (9.7) v 49.47 (10.4)
Physical QOL 49.59 (9.1) v 49.07 (9.4)
Both n = 69 v n = 65.
Northouse 2007
4 months
Physical QOL 50 (7.8) v 50.3 (7.2)
Mental QOL 50.9 (7.5) v 49 (7.5)
Cancer specific QOL 86.5 (11.3) v 83.5 (11.4)
All n =112, n = 123
Walsh 2007
9 weeks
QOL 69.3 (22.7) n = 71 v 65.2 (17) n = 59
Scores expressed as the higher the better.
*Effect measure reversed as scale, as reported by author, was in the opposite direction. See Analysis 1.3, for overall effect size. (In trials with
multiple outcomes the median effect was selected for combined trial analysis).
Table 6. Direct interventions: Quality of life at the end of follow up
Trial, time since end of treatment phase Displayed as: Intervention mean (SD) n versus (v) control mean (SD) n, standard-
ised mean difference (MD) and [confidence interval]
Carter 2006
2.5 months
QOL 44 (17) n = 15 v 39 (19) n = 15 MD -0.27 [95% CI -0.99 to 0.45]*
Northouse 2005
3 months
Mental QOL 50.81 (12.3) v 49.21 (12.0) MD 0.13 [95% CI -0.21 to 0.47]
Physical QOL 50.54 (9.7) v 48.93 (10.2) MD 0.16 [95% CI -0.18 to 0.50]
Both n = 69, n = 65.
Northouse 2007
8 months
Mental QOL 51.5 (7.6) v 52 (7.6) MD -0.07 [95% CI -0.33 to 0.20]
Physical QOL 44.6 (7.2) v 42.3 (7.2) MD 0.32 [95% CI 0.05 to 0.59]
Cancer specific QOL 85.2 (11.6) v 83.6 (11.9) MD 0.14 [95% CI -0.13 to 0.40]
All n = 104, n = 114.
Walsh 2007
6 weeks
QOL 65.2 (21.3) n = 64 v 62.2 (19.8) n = 52 MD -0.14 [955 CI -0.51 to 0.22]
Median effect size 0.13
Number of comparisons showing a positive direction of effect of intervention 5/7
Number of comparisons showing a statistically significant effect 1/7 (favouring the intervention)
Scores expressed as the higher the better the outcome
*Effect outcome reversed as scale in the opposite direction
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Table 7. Direct interventions: Physical health, sleep improvement at the end of treatment
Trial, time since baseline Outcomes displayed as: Intervention mean standard deviation (SD) n versus (v) control mean
(SD) n, standardised mean difference (MD) and confidence interval [ ]
Carter 2006
2 months
Waking after sleep onset 50 (46) v 50 (45) MD 0.00 [95% CI -0.72 to 0.72]*
Sleep latency (time to fall asleep upon going to bed)
- Actigraph 7 (6) v 15 (13) MD -0.77 [95% CI -1.51 to -0.02]*
- Self-report 12 (7) v 14 (10) MD -0.23 [95% CI -0.94 to 0.49]*
Sleep efficiency
- Actigraph 87 (9) v 83 (11) MD 0.39 [95% CI -0.34 to 1.11]
- Self-report 85.4 (10) v 78 (18) MD 0.49 [95% CI -0.23 to 1.22]
Pittsburgh Quality of Sleep Scale 6 (3) v 8.4 (5.5) MD -0.53 [95% CI -1.26 to 0.20]*
Sleep duration
- Actigraph 6.3 (1.3) v 5.2 (2.2) MD 0.59 [95% CI -0.14 to 1.33]
- Self-report 6.6 (1.5) v 5.8 (2) MD 0.44 [95% CI -0.29 to 1.17]
All n = 15 v n = 15
Median effect size 0.00
Number of comparisons showing a positive direction of effect of intervention = 6/8
Number of comparisons showing a statistically significant effect = 1/8 (favouring the intervention)
Scores expressed as the higher the better the outcome.
*Effect outcome reversed as scale in the opposite direction.
Table 8. Direct interventions: Physical health, sleep improvement at the end of follow up
Trial, time since end of treatment phase Displayed as: Intervention mean (SD) n versus (v) control mean (SD) n, standard-
ised mean difference (MD) and [confidence interval]
Carter 2006
2.5 months
Waking after sleep onset 32 (28) v 40 (39) MD 0.23 [95% CI -0.49 to 0.95]*
Sleep latency (time to fall asleep upon going to bed)
- Actigraph 10 (11) v 14 (21) MD 0.23 [95% CI -0.49 to 0.95]*
- Self-report 19 (25) v 26 (30) MD 0.25 [95% CI -0.47 to 0.97]*
Sleep efficiency
- Actigraph 91 (6) v 84 (13) MD 0.67 [95% CI -0.07 to 1.41]
Pittsburgh Quality of Sleep Scale 5.4 (3) v 10.3 (6) MD 1.01 [95% CI 0.24 to 1.77]*
Sleep duration
- Actigraph 7.5 (1.2) v 5.6 (2.0) MD 1.12 [95% CI 0.34 to 1.90]
- Self-report 7 (2) v 6 (2) MD 0.49 [95% CI -0.24 to 1.21]
All n = 15 v n = 15
Median effect size 0.49
Number of comparisons showing a positive direction of effect of intervention 6/7
Number of comparisons showing a statistically significant effect 2/7 (both favouring the intervention)
Scores expressed as the higher the score the better the outcome.
*Effect outcome reversed as scale in the opposite direction.
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Table 9. Direct interventions: Caregiver bereavement grief at the end of follow up
Trial, time since baseline Outcome unless stated otherwise displayed as: Intervention mean (SD) n v control mean
SD n, standardised mean difference (MD) and [confidence interval]
Kissane 2006
13 months
Abnormal grief expression n = 19 families, mean change score from 6 to 13 months follow-up
11.73 v 14.19, difference in mean scores -2.46 P value 0.05
Walsh 2007
4 months after death
Intensity of grief using Core Bereavement Items
47.1 (11.2), n = 82 v 45.6 (11.6) n = 96. MD 0.13 [95% CI -0.16 to 0.43]
Table 10. Direct interventions: Caregiver acceptability of intervention
Trial, time since baseline Outcome displayed as: Intervention n versus (v) control n, Odds ratio (OR)[confidence
interval]
Walsh 2007
4 months after death
Considered care poor 16/83 v 21/95 OR 0.84 [95% CI 0.41 to 1.75]
Table 11. Direct interventions: Other outcomes at the end of treatment
Trial, time since baseline Outcomes displayed as: Intervention mean standard deviation (SD) n versus (v) control mean
(SD) n, standardised mean difference (MD) and [confidence interval]
Allen 2008
One week
Daily spiritual experience 30.71 (3.5) n = 17 v 31.29 (3.73) n = 14 MD -0.16 [95% -0.87 to 0.55]
Meaning 7.06 (0.75) n = 17 v 7.0 (0.78) n = 14 MD 0.08 [95% CI -0.63 to 0.78]
Kissane 2006
6 months
Social Adjustment Scale 0.06 v 0.05, difference in mean scores since baseline 0.01 [95% CI -0.74 to 0.
09]
Family Assessment Devise: General Functioning Scale 0.04 v 0.01, difference in mean scores since
baseline 0.06 [95% CI 0.05 to 0.17]
Northouse 2007
4 months
Communication with care receiver mean 3.74 (0.53) n = 112 v 3.57 (0.56) n = 123 MD = 0.31 [95%
CI -0.05 to 0.57]
Number of comparisons showing a positive direction of effect of intervention 4/5
Number of comparisons showing a significant effect 1/5 (favouring the intervention)
*These outcomes are a measure of caregiver’s wellbeing but did not form part of the review’s primary outcome. A median effect was not reported
because of heterogeneity in type of outcomes. Meaning, daily spiritual experience and communication are reported as the higher the score
the more the participant is experiencing the outcome being measured. Social Adjustment Scale and the Family Assessment Devise Scale are
reported as the lower the better the outcome.
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Table 12. Direct interventions: Patient psychological outcomes at the end of treatment
Trial, time since baseline Displayed as: Intervention mean (SD) n versus (v) control mean (SD) n, stan-
dardised mean difference (MD) and [confidence interval]
Allen 2008
One week
Patient self-report
Subjective wellbeing 4.47 (1.73) n = 17 v 4.93 (1.07) n = 14 MD -0.30 [95% CI -
1.02 to 0.41]
Depression 15.3 (11.54) n =10 v 14.58 (9.55) n = 12 MD 0.07 [95% CI -0.91 to
0.77]*
Talkativeness 4.47 (3.34) v 2.71 (2.27) MD 0.59 [95% CI -0.14 to 1.31]
Agitation 3.43 (2.62) v 2.21 (2.58) MD -0.46 [95% CI -1.17 to 0.26]*
Caregiver report
Talkativeness 4.94 (2.77) v 2.64 (1.69) MD 0.95 [95% CI 0.20 to 1.71]
Agitation 4.35 (2.89) v 4.64 (2.76) MD 0.10 [95% CI -0.61 to 0.81]*
Talkativeness and agitation outcomes all n = 17, n = 14.
Keefe 2005
Mean 6 days, (range 0 to 31 days)
Physical wellbeing 2.02 (0.77) v 2.08 (0.77) MD -0.08 [-0.60, 0.45]
Social/family wellbeing 3.55 (0.52) v 3.33 (0.52) MD 0.42 [95% CI -0.11 to 0.95]
Both n = 28 v n = 28
Northouse 2005
3 months
Negative appraisal of illness 3.03 (0.74) v 3.00 (0.82) MD -0.04 [95% CI -0.38 to
0.30]*
Uncertainty 70.13 (15.2) v 70.52 (15.2) MD 0.03 [95% CI -0.31to 0.36]*
Hopelessness 3.56 (4.3) v 3.96 (4.1) MD 0.09 [95% CI -0.24 to 0.43]*
Active coping 6.25 (1.1) v 6.29 (1.1) MD -0.04 [95% CI -0.37 to 0.30]
Avoidant coping 4.05 (0.90) v 3.91(0.77) MD -0.17 [95% CI -0.51 to 0.17]*
Mental QOL 51.34 (9.5) v 49.13(9.9) MD 0.23 [95% CI -0.11 to 0.57]
Physical QOL 50.80 (9.3) v 49.9 0 (9.8) MD 0.09 [95% CI -0.25 to 0.43]
All n = 69 v n = 65
Northouse 2007
4 months
Negative appraisal of illness 2.16 (0.74) v 2.23 (0.71) MD 0.10 [95% CI -0.16 to
0.35]*
Uncertainty 56.9 (14.2) v 60 (13.5) MD 0.22 [95% CI -0.03 to 0.48]*
Hopelessness 2.23 (2.4) v 2.69 (3.1) MD 0.16 [95% CI -0.09 to 0.42]*
Active coping 31.3 (5.7) v 31 (6) MD 0.05 [95% CI -0.20 to 0.31]
Avoidant coping 14.4 (2.8) v 14.2 (2.7) MD -0.07 [95% CI -0.33 to 0.18]*
Physical QOL 48.6 (6.7) v 48.7 (6.5) MD -0.02 [95% CI -0.27 to 0.24]
Mental QOL 52.4 (6.5) v 51.9 (6.6) MD 0.08 [95% CI -0.18 to 0.33]
Cancer specific QOL 87.2 (10.6) v 85.5 (10.3) MD 0.16 [95% CI -0.09 to 0.42]
Self-efficacy 146.1 (19) v 146 (20.2) MD 0.01 [95% CI -0.25 to 0.26]
Communication 3.80 (0.46) v 3.69 (0.52) MD 0.22 [95% CI -0.03 to 0.48]
All n = 112 v n = 123
Median effect 0.03
Number of comparisons showing a positive direction of effect of intervention 17/26
Number of comparisons showing a statistically significant effect 1/26 (favouring the intervention)
Scores expressed as the higher the better the outcome *Effect measure reversed as scale in the opposite direction
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Table 13. Direct interventions: Patient physical outcomes at the end of treatment
Trial, time since baseline Displayed as: Intervention mean (SD) n versus (v) control mean (SD) n stan-
dardised mean difference (MD) and [confidence interval]
Allen 2008
One week
Patient self-report:
Symptom score 14.27 (9.19) v 15.35 (10.29) MD -0.11 [95% CI -0.82 to 0.60]
Additional symptom:
Weight loss 3.93 (3.06) v 3.93 (3.61) MD 0.00 [95% CI -0.71 to 0.71]
Caregiver assessment of patient:
Overall symptom score 24.53 (15.07) v 21.71 (9.54) MD 0.21 [95% CI -0.50 to
0.92]
Additional symptom:
Weight loss 3.59 (3.32) v 1.57 (1.10) MD 0.76 [95% CI 0.03 to 1.50]
All n = 17, n = 14.
Keefe 2005
Mean 6 days, (range 0 to 31 days)
Patient pain intensity
Worse 6.46 (2.15) v 6.93 (2.15) MD -0.22 [95% CI-0.75 to 0.30]
Both n = 28 v n = 28
Northouse 2007
4 months
Self report:
Symptom distress 5.99 (3.6) v 6.19 (3.6) MD -0.06 [95% CI -0.31 to 0.20]
Urinary symptoms 86.9 (12.7) v 81.6 (13.8) MD 0.40 [95% CI 0.14 to 0.66]
Bowel symptoms 89.5 (7) v 90.3 (8.4) MD -0.10 [95% CI -0.36 to 0.15]
Sexual symptoms 28.5 (21.4) v 29.3 (20.9) MD -0.04 [95% CI -0.29 to 0.22]
Hormone symptoms 83.7 (9.9) v 83.8 (10.4) MD -0.01 [95% CI -0.27 to 0.25]
All n = 112 v n = 123
Median effect -0.04
Number of comparisons showing a positive direction of effect of intervention 5/10
Number of comparisons showing a statistically significant effect 2/10 (favouring the comparison group)
Scores expressed as the lower the better the outcome
Table 14. Direct interventions: Other patient outcomes at the end of treatment
Trial, time since baseline Outcome displayed as: Intervention mean (SD) n v control mean (SD) n, Standardised mean
difference (MD) and [confidence interval]
Allen 2008
One week
Daily spiritual experience 28.86 (4.19) v 31.36, (2.76) MD -0.67 [95% CI -1.40 to 0.06]
Meaning 7.21 (0.8) v 6.43 (1.28) MD 0.73 [95% CI -0.01 to 1.46]
For both n = 17 v n = 14
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Table 15. Indirect interventions: Psychological distress at end of treatment
Trial, time since baseline Outcome* unless states otherwise displayed as: Intervention propor-
tion with distress v control proportion with distress, Odds ratio (OR)
[confidence interval]
Addington-Hall 1992 follow-up before death of patient Depression* 21/56 v 25/62 OR 0.89 [95% CI 0.42 to 1.86]
Anxiety* 22/56 v 32/62 OR 0.61 [95% CI 0.29 to 1.26]
Number of comparisons showing a positive direction of effect 2/2
Number of comparisons showing a statistically significant effect 0/2
*Number of caregivers with scores above cut off for psychological morbidity on the Leeds Anxiety and Depression Scale
Table 16. Indirect interventions: Psychological distress at the end of follow up
Trial, time since end of treatment phase Outcome displayed as either: Intervention OR (odds ratio) or
mean (SD) n versus (v) control, standardised mean difference
(MD) [confidence interval]
Addington-Hall 1992
Unclear but in bereavement
Depression* 20/51 v 19/40 OR 0.71 [95% CI 0.31 to 1.65]
Anxiety* 10/51 v 13/40 OR 0.51 [95% CI 0.19 to 1.32]
Felt angry when they thought about the patient’s death 8/51 v 15/
40 OR 0.31 [95% CI 0.12 to 0.83]
Kane 1984
Assessments were taken as overall during the follow-up
Depression states ’no significant differences’. Anxiety using 5 co-
horts per trial arm (cohort groupings are by number of sessions at-
tended); 3/5 cohorts they report there was a significant difference
(P < 0.01) between the trial arms that favoured the intervention
group
Number of comparisons showing a positive direction of effect** 3/3
Number of comparisons with significant outcomes** 0/3
*Number of caregivers with scores above cut off for psychological morbidity on the Leeds Anxiety and Depression Scale.
**Only one trial provided full data
Table 17. Indirect interventions: Physical health
Trial, time since baseline Outcome displayed unless stated otherwise as Intervention
mean (SD) n versus (v) control mean (SD) n, standardised
mean difference (MD) and [confidence interval]
Addington-Hall 1992 follow-up before and after patient’s death Physical health: There were no differences in the proportions
of caregivers of each group reporting excellent or good physical
health, in the proportion feeling physically ill in some way, or in
the proportion reporting that their health was at least as good as
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Table 17. Indirect interventions: Physical health (Continued)
it was before the patient’s death
Table 18. Accceptability of intervention by patient and caregiver
Trial, time since baseline Outcomes
Addington-Hall 1992* Caregiver and patient satisfaction with care services did not differ significantly between groups, nor did
caregiver satisfaction with place of death
Kane 1984* Overall, hospice patients were more satisfied than control patients. Specifically, consistent significant
difference between control and intervention groups in interpersonal care, and in four of the five cohorts
on involvement with care. There was no difference in satisfaction in physical care environment between
the two comparative groups. For family caregivers there was overall no consistent difference in satisfaction
with care in interaction with professional, and involvement with care
*Does not provide summary information on time since baseline
Table 19. Indirect interventions: Patient treatment and service utilisation
Trial, time since baseline Outcomes. Numerical findings displayed intervention v control, odds ratio (OR)[confidence in-
terval]
Addington-Hall 1992* Home helps 41 v 43 OR 0.86 [95% CI 0.49 to 1.51]
Meals on wheels 15 v 18 OR 0.77 [95% CI 0.36 to 1.62]
Social worker 7 v 12 OR 0.53 [95% CI 0.20 to 1.40]
Physiotherapist 3 v 2 OR 1.46 [95% CI 0.24 to 8.90]
Occupational therapist 6 v 3 OR 1.98 [95% CI 0.48 to 8.14]
Chiropodist 7 v 1 OR 7.15 [95% CI 0.86 to 59.18]
Special laundry services 2 v 3 OR 0.63 [95% 0.10 to 3.88]
District nurses 38 v 39 OR 0.90 [95% CI 0.51 to 1.59]
Oncology sister 14 v 13 OR 1.04 [95% CI 0.46 to 2.34]
Hospice or MacMillan sister 7 v 11 OR 0.58 [95% CI 0.22 to 1.57]
GP home visit 23 v 23 OR 0.95 [95% CI 0.49 to 1.83]
GP surgery consultation 13 v 18 OR 0.65 [95% CI 0.30 to 1.41]
N = 103 v n = 99
There were no group difference in the type of analgesics taken, nor in the proportions of patients taking
anti-emetics, laxatives, antidepressant drugs, sedatives or anxiolytics, or in the proportion having unmet
needs or who had aids and appliances for use in their home
Kane 1984* There were no statistically significant differences in the total number of days spent in the hospital by
hospice and controls patients. Hospice patients spent fewer days in general medical wards (13.2 v 20.7)
and in nursing homes (1 v 11.4) than controls, and spent more days at home 44.8 v 37.9
Had major surgical procedures 0.09 v 0.01, minor surgical procedure 0.42 v 0.30, radiation treatment
7.4 v 7.7, or chemotherapy 1.3 v 0.49
Place of death did not differ significantly between the groups
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Table 19. Indirect interventions: Patient treatment and service utilisation (Continued)
Median effect 0.86 **
Number of comparisons showing a positive direction of effect in increasing services 4/12 **
Number of comparisons with significant outcomes 0/12 **
*Does not provide summary information on time since baseline
** Summary outcomes only for fully reported data
Table 20. Indirect interventions: Patient psychological outcomes at the end of treatment
Trial, time since baseline Outcomes. Numerical findings displayed as: Intervention versus (v) con-
trol, summary measure odds ratio (OR)[confidence interval]/standard-
ised mean difference (MD) [confidence interval]
Addington-Hall 1992
Time since baseline not stated
Depression* 17/85 v 28/77, OR 0.44 [95% CI 0.22 to 0.89]
Anxiety* 12/85 v 20/77, OR 0.47 [95% CI 0.21 to 1.04]
Kane 1984** No significant difference reported in for depression or anxiety scores. Al-
though patients in the intervention group had consistently lower scores for
depression than those in the control
Number of comparisons showing a positive direction of effect 2/2
Number of comparisons with significant outcomes 1/2
*Number of caregivers with scores above cut off for psychological morbidity on the Leeds Anxiety and Depression Scale
**Does not provide complete data
Table 21. Indirect interventions: Patient physical outcomes at the end of treatment
Trial, time since baseline Outcomes. Numerical findings displayed as: Intervention versus (v)
control, summary measure odds ratio (OR)[confidence interval]
Addington-Hall 1992*
Caregiver report last week of life
Pain 55 v 56 OR 0.86 [95% CI 0.50 to 1.50]
Loss of appetite 54 v 49 OR 1.10 [95% CI 0.64 to 1.91]
Difficulty swallowing 9 v 14 OR 0.58 [95% CI 0.24 to 1.40]
Vomiting 4 v 11 OR 0.32 [95% CI 0.10 to 1.04]
Nausea 20 v 19 OR 1.00 [95% CI 0.50 to 2.02]
Breathlessness 61 v 61 OR 0.88 [95% CI 0.50 to 1.55]
Cough 36 v 37 OR 0.89 [95% CI 0.50 to 1.57]
Itchy skin 27 v 30 OR 0.81 [95% CI 0.44 to 1.49]
Constipation 31 v 36 OR 0.74 [95% CI 0.41 to 1.34]
Diarrhoea 10 v 6 OR 1.65 [95% CI 0.58 to 4.72]
Incontinence or retention 15 v 21 OR 0.63 [95% CI 0.30 to 1.30]
Sleeplessness 35 v 37 OR 0.85 [95% CI 0.48 to 1.51]
All n = 104, n = 99
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Table 21. Indirect interventions: Patient physical outcomes at the end of treatment (Continued)
’there were few statistically significant differences in severity of symptoms,
concern about symptoms and effectiveness of treatment’
Kane 1984** ’The survival curves for hospice and control groups were essentially the
same’
No significant difference reported in symptom score or activities of daily
living scores
Median effect 0.85
Number of comparisons showing a positive direction of effect 10/12***
Number of comparisons with significant outcomes 0/12***
*Authors report ORs that are adjusted for baseline scores and change in randomisation, these do not differ in direction or significant
to these report in this table
** Does not provide complete data
*** Only reported for outcomes where full data is provided
A P P E N D I C E S
Appendix 1. Search strategy for Cochrane Central
1. terminal* or palliative or dying or hospice or “end of life” or endstage or ((advanced or late or last or end or final) next (stage or
phase))
2. “advanced cancer”:kw
3. (#1 OR #2)
4. (family or families or parent or friend or relative or spouse or partner or husband or wife or wives or child or children or (close
next person) or (significant next other)) and (care* or caring)
5. (family or families or parent or friend or relative or spouse or partner or husband or wife or wives or child or children or (close
next person) or (significant next other)) near/10 (support* or information or help* or assist* or service or improv* or enhanc* or
benefit or train* or educat* or teach* or advis* or advice or counsel* or intervention or therap* or program* or need* or burden or
quality or outcome or satisfaction or “well being” or well being or psycho* or social or pastoral or spiritual or religio* or (future
next plan*) or coping or “problem solving” or relaxation or respite or retreat or sleep or massage or yoga or meditation or
reflexology or acupuncture or listen* or advocate or “day care” or daycare)
6. MeSH descriptor Professional-Family Relations, this term only
7. “human relation”:kw
8. “social support”:kw
9. “family health”:kw
10. family next (centered or centred or focused or focussed)
11. MeSH descriptor Psychotherapy explode all trees
12. psychotherap*
13. “pastoral care”:kw
14. counseling:kw
15. education:kw
16. “health education”:kw
17. teaching:kw
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18. MeSH descriptor Complementary Therapies explode all trees
19. “alternative medicine”:kw
20. MeSH descriptor Religion explode all trees
21. religion:kw
22. (#5 OR #6 OR #7 OR #8 OR #9 OR #10 OR #11 OR #12 OR #13 OR #14 OR #15 OR #16 OR #17 OR #18 OR #19
OR #20 OR #21)
23. (#4 AND #22)
24. carer* or caregiv* or (care next giv*)
25. MeSH descriptor Home Nursing explode all trees
26. “family nursing”:kw
27. “family therapy”:kw
28. “home care”:kw
29. “respite care”:kw
30. parent:kw
31. spouse:kw
32. (#23 OR #24 OR #25 OR #26 OR #27 OR #28 OR #29 OR #30 OR #31)
33. (#3 AND #32)
34. (#33) in Clinical Trials
35. sr-commun in Clinical Trials
36. (#34 AND #35) in Clinical Trials
Appendix 2. Search strategy for Medline
1. (terminal* or palliative or dying or hospice* or end of life or endstage or ((advanced or late or last or end or final) adj (stage* or
phase*))).tw.
2. terminally ill/
3. terminal care/
4. palliative care/
5. hospice care/
6. hospices/
7. or/1-6
8. (family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or close
person? or significant other?).tw. and (care* or caring).mp.
9. ((family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or close
person? or significant other?) adj10 (support* or information or help* or assist* or service* or improv* or enhanc* or benefit* or train*
or educat* or teach* or advis* or advice* or counsel* or intervention* or therap* or program* or need* or burden or quality or outcome*
or satisfaction or well being or well being or psycho* or social or pastoral or spiritual or religio* or future plan* or coping or problem
solving or relaxation or respite or retreat or sleep or massage or yoga or meditation or reflexology or acupuncture or listen* or advocate*
or day care or daycare)).tw.
10. professional family relations/
11. social support/
12. family health/
13. (family adj (cent?red or focus?ed)).tw.
14. exp psychotherapy/
15. exp counseling/
16. education/
17. health education/
18. teaching/
19. exp complementary therapies/
20. exp religion/
21. or/9-20
22. 8 and 21
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23. (carer* or caregiv* or care giv*).tw.
24. caregivers/
25. exp home nursing/
26. family nursing/
27. family therapy/
28. spouses/
29. parents/
30. or/22-29
31. 7 and 30
32. randomized controlled trial.pt.
33. controlled clinical trial.pt.
34. random*.tw.
35. placebo*.tw.
36. drug therapy.fs.
37. trial.tw.
38. groups.tw.
39. clinical trial.pt.
40. evaluation studies.pt.
41. research design/
42. follow up studies/
43. prospective studies/
44. (control* or prospectiv* or volunteer*).tw.
45. cross over studies/
46. comparative study.pt.
47. experiment*.tw.
48. time series.tw.
49. (pre test or pretest or post test or posttest).tw.
50. (pre intervention or preintervention or post intervention or postintervention).tw.
51. (impact* or intervention* or chang*).tw.
52. effect?.tw.
53. or/32-52
54. humans.sh.
55. 53 and 54
56. 31 and 55
Appendix 3. Search strategy for EMBASE
1. (terminal* or palliative or dying or hospice* or end of life or endstage or ((advanced or late or last or end or final) adj (stage* or
phase*))).tw.
2. exp terminally ill patient/
3. terminal disease/
4. advanced cancer/
5. terminal care/
6. exp palliative therapy/
7. palliative nursing/
8. hospice care/
9. hospice/
10. hospice nursing/
11. or/1-10
12. (family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or close
person? or significant other?).tw. and (care* or caring).mp.
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13. ((family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or
close person? or significant other?) adj10 (support* or information or help* or assist* or service* or improv* or enhanc* or benefit* or
train* or educat* or teach* or advis* or advice* or counsel* or intervention* or therap* or program* or need* or burden or quality or
outcome* or satisfaction or well being or well being or psycho* or social or pastoral or spiritual or religio* or future plan* or coping or
problem solving or relaxation or respite or retreat or sleep or massage or yoga or meditation or reflexology or acupuncture or listen* or
advocate* or day care or daycare)).tw.
14. human relation/
15. social support/
16. family health/
17. (family adj (cent?red or focus?ed)).tw.
18. exp psychotherapy/
19. counseling/
20. bereavement counseling/
21. family counseling/
22. education/
23. health education/
24. teaching/
25. alternative medicine/
26. religion/
27. or/13-26
28. 12 and 27
29. (carer* or caregiv* or care giv*).tw.
30. caregiver/
31. exp home care/
32. family nursing/
33. family therapy/
34. spouse/
35. parent/
36. or/28-35
37. 11 and 36
38. Randomized Controlled Trial/
39. random*.tw.
40. experiment*.tw.
41. time series.tw.
42. (pre test or pretest or post test or posttest).tw.
43. impact.tw.
44. intervention*.tw.
45. chang*.tw.
46. evaluat*.tw.
47. effect?.tw.
48. compar*.tw.
49. control*.tw.
50. or/38-49
51. nonhuman/
52. 50 not 51
53. 37 and 52
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Appendix 4. Search strategy for PsycINFO
1. (terminal* or palliative or dying or hospice* or end of life or endstage or ((advanced or late or last or end or final) adj (stage* or
phase*))).tw.
2. terminally ill patients/
3. terminal cancer/
4. palliative care/
5. hospice/
6. or/1-5
7. (family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or close
person? or significant other?).tw. and (care* or caring).mp.
8. ((family or families or parent? or friend? or relative? or spouse? or partner? or husband? or wife or wives or child or children or close
person? or significant other?) adj10 (support* or information or help* or assist* or service* or improv* or enhanc* or benefit* or train*
or educat* or teach* or advis* or advice* or counsel* or intervention* or therap* or program* or need* or burden or quality or outcome*
or satisfaction or well being or well being or psycho* or social or pastoral or spiritual or religio* or future plan* or coping or problem
solving or relaxation or respite or retreat or sleep or massage or yoga or meditation or reflexology or acupuncture or listen* or advocate*
or day care or daycare)).tw.
9. social support/
10. exp psychotherapy/
11. counseling/
12. pastoral counseling/
13. (family adj (cent?red or focus?ed)).tw.
14. education/
15. health education/
16. client education/
17. teaching/
18. exp alternative medicine/
19. exp religious practices/
20. spirituality/
21. or/8-20
22. 7 and 21
23. (carer* or caregiv* or care giv*).tw.
24. caregivers/
25. caregiver burden/
26. respite care/
27. home care/
28. elder care/
29. family therapy/
30. spouses/
31. parents/
32. or/22-31
33. 6 and 32
34. random*.tw.
35. experiment*.tw.
36. trial.tw.
37. placebo.ab.
38. groups.ab.
39. ((singl* or doubl* or trebl* or tripl*) and (blind* or mask*)).tw.
40. time series.tw.
41. time series/
42. (pre test or pretest or post test or posttest).tw.
43. (pre intervention or preintervention or post intervention or postintervention).tw.
44. (cross over or crossover).tw.
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45. latin square.tw.
46. (prospective* or volunteer*).tw.
47. impact.tw.
48. intervention*.tw.
49. chang*.tw.
50. evaluat*.tw.
51. effect?.tw.
52. compar*.tw.
53. control*.tw.
54. treatment effectiveness evaluation/
55. mental health program evaluation/
56. exp experimental design/
57. or/34-56
58. limit 57 to human
59. 33 and 58
Appendix 5. Search strategy for CINAHL
1. terminal* or palliative or dying or hospice* or “end of life” or endstage
2. advanced stage* or advanced phase* or late stage* or late phase* or last stage* or last phase* or end stage or end phase or final stage*
or final phase*
3. 1 or 2
4. (family or families or parent* or friend* or relative* or spouse* or partner* or husband* or wife or wives or child or children or close
person* or significant other*) and (care* or caring)
5. (family or families or parent* or friend* or relative* or spouse* or partner* or husband* or wife or wives or child or children or close
person* or significant other*) and (support* or information or help* or assist* or service* or improv* or enhanc* or benefit* or train* or
educat* or teach* or advis* or advice* or counsel* or intervention* or therap* or program* or need* or burden or quality or outcome*
or satisfaction or well being or well being or psycho* or social or pastoral or spiritual or religio* or future plan* or coping or problem
solving or relaxation or respite or retreat or sleep or massage or yoga or meditation or reflexology or acupuncture or listen* or advocate*
or day care or daycare)
6. MH professional-family relations
7. MH family health
8. family cent*red or family focus*ed
9. MH home health care 10. MH psychotherapy+
11. MH counseling
12. MH education
13.MH health education
14. MH alternative therapies+
15. spiritual*
16. MH “religion and religions+”
17. 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16
18. 4 and 17
19. carer* or caregiv* or care giv*
20. MH home nursing
21. MH family nursing
22. MH family therapy
23. MH respite care
24. MH spouses
25. MH parents
26. 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25
27. 3 and 26
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28. randomi?ed controlled trial*
29. MH Experimental Studies+
30. MH Random Assignment
31. MH Comparative Studies
32. MH Crossover Design
33. MH Placebos
34. MH Quantitative Studies
35. MH Quasi-Experimental Studies+
36. PT Clinical Trial
37. 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36
38. AB (random* or trial or groups or placebo* or experiment* or control* or compar* or intervention* or chang* or evaluat* or impact*
or effect?) or TI (random* or trial or groups or placebo* or experiment* or control* or compar* or intervention* or chang* or evaluat*
or impact* or effect?)
39. AB ((singl* or doubl* or tripl* or trebl*) and (blind* or mask*)) or TI ((singl* or doubl* or tripl* or trebl*) and (blind* or mask*))
40. AB time series or TI time series
41. AB (pre test or pretest or post test or posttest or pre intervention or preintervention or post intervention or postintervention) or TI
(pre test or pretest or post test or posttest or pre intervention or preintervention or post intervention or postintervention)
42. 38 or 39 or 40 or 41
43. 37 or 42
44. 27 and 43
45. 44 Limiters - Exclude MEDLINE records
Search modes - Boolean/Phrase
* All Search modes - Boolean/Phrase except
Appendix 6. Details on analysis categories and outcomes per trial
Primary outcome categories where data per trial was available:
Psychological distress
The review’s outcome category of psychological distress included per trial:
Allen 2008
• Symptoms of depression using the CES-D (Radloff 1977).
Carter 2006
• Symptoms of depression using the CES-D (Radloff 1977)
Hudson 2005
• Symptoms of anxiety using the Hospital Anxiety and Depression Scale (Zigmond 1983)
Northouse 2005, Northouse 2007
• Feelings of hopelessness using the Beck Hopelessness Scale (Beck 1974)
Keefe 2005
• Negative and positive mood using the Profile of Mood States-B (Lorr 1982)
Kissane 2006
• Psychological morbidity using the Brief Symptom Inventory (Derogatis 1982)
• Symptoms of depression using the Beck Depression Inventory (Beck 1972)
Walsh 2007
• Symptoms of depression using the General Health Questionnaire-28 (Goldberg 1970)
Coping with the caring role
The review’s outcome category of coping with the caring role included per trial:
Allen 2008
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• Caregiving competency, strain, role overload, role capacity and emotional control measured using The Caregiver Stressors Scale
(Zarit 1998)
Hudson 2005
• Perceived readiness for their role using the Preparedness for Caregiving Scale (Archbold 1996)
• Perceived adequacy using the Caregiver Competence Scale (Pearlin 1990)
• Perceived potential positive aspects associated with being a caregiver using the Rewards of Caregiving (Archbold 1996)
• Perceived control over caring role using the Caregiving Appraisal Scale subscale on mastery (Lawton 1989)
• The belief they can initiate or participate in courses of action that are intended to reduce stress and heighten wellbeing and that
they can use problem-solving self-care behaviours measured using the Self Efficacy Instrument (Zeiss 1999)
Keefe 2005
• To assess the level of strain experienced using the Caregiver Strain Index (Robinson 1983)
• To assess confidence in the ability to help the patient manage pain using the caregiver version of the Chronic Pain Self-Efficacy
Scale (Anderson 1995)
McMillan 2005
• To assess the ability to adapt to problems (burden of patient’s cancer symptoms) using an adaptation of the Memorial Symptom
Assessment Scale (Portenoy 1994)
• Mastery in care-giving using a six-item scale (Moody 1990)
• To assess burden and mastery in caregiver role measured using the Caregiver Demands Scale (Stetz 1987)
• Problem focused and emotion focused coping using the Brief COPE Scale (Carver 1997
Northouse 2005 and 2007
• Coping strategies of self-distraction, active coping, denial, alcohol/drug use, emotional support, behavioural disengagement,
venting, positive reframing, planning, use of humour, acceptance, and religion using the Brief COPE Scale (Carver 1997)
• Negative appraisal of caregiving using the Appraisal of Care-giving Scale (Oberst 1991)
• Feelings of uncertainty using the Mischel Uncertainty in Illness Scale (Mischel 1983)
Northouse 2007
• The extent to which husbands prostate-specific symptoms created problems for their spouses using the spousal version of the
Prostrate Cancer Index (Northouse 2007b)
• Confidence in managing stress and changes associated with cancer or treatment using the Self-efficacy Scale (Lewis 1996)
Walsh 2007
• Strain relating to providing care using the Carer Strain Index (Robinson 1983)
Quality of life
The review category included outcomes on wellbeing as well as quality of life in this category. Per trial these were measured using the
following scales:
Allen 2008
• Psychological wellbeing (Tran 1991)
Carter 2006
• Caregiver Quality of Life Index (Cancer) (Weitzner 1999)
McMillian 2006
• Caregiver Quality of Life Index (Cancer) (Weitzner 1999)
Northouse 2005
• The General Functional Assessment of Cancer Treatment (Cella 1993)
• SF-36 Health Survey (Ware 1993)
Northouse 2007
• Medical Outcomes Study (Ware 1996)
• The General Functional Assessment of Cancer Treatment (Cella 1993)
Walsh 2007
• Caregiver Quality of Life Index (Cancer) (Weitzner 1999
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WH A T ’ S N E W
Last assessed as up-to-date: 30 April 2010.
Date Event Description
16 May 2011 Amended Declaration of interest updated to include declaration by Michael King
H I S T O R Y
Protocol first published: Issue 1, 2009
Review first published: Issue 6, 2011
C O N T R I B U T I O N S O F A U T H O R S
LJ and BC conceived the idea for the review. RD and BL provided statistical advice. BC drafted the review on which LJ, MK, RD, BL
and AT provided constructive comment. BC is guarantor of the review.
D E C L A R A T I O N S O F I N T E R E S T
LJ and MK were co-authors of the included study Walsh 2007. Neither LJ nor MK was involved in extracting data from this study.
Data extraction for all trials was reviewed critically and checked repeatedly by BL.
S O U R C E S O F S U P P O R T
Internal sources
• Marie Curie Palliative Care Research Unit, UK.
External sources
• No sources of support supplied
D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
TheMethods section has been revised. We no longer include non randomised trials in light of identifying more RCTs than we expected.
We have also provided more detail on our inclusion criteria for participants and the intervention. In order to improve the clarity of
the findings, we used new methodological approaches for combining trial evidence, as described in the section on meta-analytical
framework. We have also extended our search by handsearching key journals.
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I N D E X T E R M S
Medical Subject Headings (MeSH)
∗Social Support; Adaptation, Psychological; Caregivers [∗psychology]; Family [psychology]; Friends [psychology]; Randomized Con-
trolled Trials as Topic; Stress, Psychological [∗prevention & control]; Terminal Care [∗psychology]
MeSH check words
Adult; Humans
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